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CHAPTER 1.  CONTRIBUTIONS OF THE GUT MICROBIOTA TO HOST HEALTH 
AND RESISTANCE TO DISEASE 
 
Summary 
 
 Swine are an important agricultural commodity, and global swine production is 
increasing.  Currently antibiotics are extensively used in commercial swine production for the 
treatment and prevention of diseases.  However, the rise of antimicrobial resistance (AMR) 
necessitates that we reexamine our use of antibiotics, and reduce their use whenever possible.  
Alternatives to antibiotics are needed if we are to successfully mitigate AMR while still ensuring 
the health of swine and the safety of the food they produce.  The intestinal microbiota is 
increasingly being manipulated in a number of ways to provide alternatives to antibiotic 
treatment, and progress is being made in this regard.  Here we examine the role of the swine 
intestinal microbiota, particularly the butyrate-producing community, in health and resistance to 
disease, and investigate how manipulations of this community can provide an alternative to 
antibiotics.  What follows is a broad overview of the intestinal ecosystem, the beneficial 
functions performed by intestinal symbionts, some methods to manipulate these communities, 
and a summary of how the subsequent work outlined in this manuscript contributes to the goal of 
utilizing the functions of the gut microbiota as a way to promote health and reduce antibiotic 
treatment.  
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Introduction to the gut microbiota 
 
Microbes are ubiquitous on our planet and are critical for understanding any biological 
system, particularly an organism’s health and resistance to disease. Virtually every macroscopic 
organism has a robust community of microbial symbionts colonizing every exposed epithelial 
surface.  These symbionts are important for the health and survival of their hosts, and in many 
cases the host and its symbionts are inseparable (1, 2).  Mammals are not exempt from heavy 
microbial colonization, and every tissue contacting the outside environment is colonized by 
microbes (3).  Different tissues have different microbial communities reflecting the conditions of 
each site.  Often, these microbial communities are not passive hitchhikers, but have an important 
role in the functioning and health of these tissues.  Different regions of skin have distinct 
microbial communities (4), and variation within these distinct communities have wide-ranging 
implications, from severity of underarm odors (5), to susceptibility to foot fungus (6).  Similarly, 
the vaginal microbiome is highly specialized to exclude potential pathogens from colonizing 
these tissues (7), and deviations from a healthy community structure has serious health 
implications such as altering susceptibility to HIV infection (8).  These different microbiomes 
are undeniably important; however, the microbiome of the gastrointestinal (GI) tract has a 
special role in the health of the host organism.  
Two main GI tract conformations exist: foregut fermenters (ruminants, e.g., cattle, bison, 
deer) and hindgut fermenters (e.g., mice, humans, swine).  The main difference between these 
two configurations is that foregut fermenters have a specialized organ, often called a rumen, 
which is a large microbial fermentation vat located after their esophagus at the beginning of the 
GI tract.  In the rumen, a complex ecosystem of microbes digest plant matter and ferment it into 
short chain fatty acids (SCFAs) such as acetate, propionate, and butyrate that host tissues absorb.  
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Because initial digestion is delegated to microbes, the host need not produce all the enzymes 
required to digest the diverse plant-derived substrates from the diet.  Instead, microbial genomes 
encode these capabilities, and they encode a great diversity of enzymes to participate in the 
breakdown of dietary substrates.  Additionally, as the microbial communities in the rumen 
change in response to new food substrates, so too does the enzymatic digestive capacity of the 
rumen (9, 10).  Foregut fermenters are so dependent on their microbial partners that they cannot 
survive without them; this is in contrast to hindgut fermenters, such as humans and swine, where 
the host can technically survive without intestinal microbes.  In hindgut fermenters the colon and 
cecum are somewhat analogous to the rumen of foregut fermenters, and the remainder of this 
chapter focuses on the role of the intestinal microbiota in health and disease of hindgut 
fermenters, with a focus on swine where data are available. 
Importance of studying the swine gut microbiota 
Much more effort has been expended researching the intestinal microbiota of humans and 
lab rats compared to swine; however, investigating swine-associated microbes and their 
interactions with the host is important.   Humans and swine have remarkably similar GI tract 
configurations, and swine are generally considered to be much more similar to humans than the 
most popular laboratory animals used for biomedical testing: mice, rats, and dogs (11).  Swine 
are omnivorous just as humans and have the same general gut segments, though these differ in 
some ways.  The gross anatomy of the small intestine differs slightly in that swine have 
relatively longer sections of duodena and shorter ilea than humans, though the differences are 
more pronounced in the large intestine.  Swine have a very pronounced cecum, which is the 
dead-end pouch directly after the ileum.  This structure in humans is little more than an 
enlargement of the proximal colon just distal of the ileum (11). The anatomic layout of the swine 
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colon is quite different from humans. It is described as a ‘spiral colon’ being composed of 
several spiraling segments that loops in on itself as it progresses towards the rectum.  Gross 
anatomy aside, the structure and function of the epithelia and protective mucus layer are quite 
similar between the two species.   Researchers have successfully transplanted human microbes 
into the swine intestinal tract, generating swine with humanized gut microbiota (12), showing 
that the environments within the two species are similar enough to support the same microbial 
populations under artificial conditions.   
In addition to the pig’s similarity to humans and its use as a biomedical model organism, 
swine are a globally important food animal.  Antibiotics are used frequently in swine agriculture 
and their use is expected to continue to rise (13). Consequently, swine have been identified as a 
potential source of multidrug-resistant bacteria as well as zoonotic enteric pathogens (14).  
Knowledge of the intestinal microbiota of swine is critical to help develop strategies to mitigate 
these concerns.  The pig’s use as a model for human health as well  as its global importance as a 
livestock animal make understanding the intestinal microbiota and its interactions with the host 
of great interest to both livestock producers and medical professionals. 
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Differing niches throughout the GI tract 
The GI tract consists of all the tissues spanning from the oral cavity to the rectum, and the 
distribution of microbes is different throughout the different gut sections.  The epithelia of the GI 
tract represents the largest exposure of host tissues to the outside environment, and in humans the 
GI mucosa has a surface area of over 40 m2 (15). Much of this area is specialized absorptive 
structures in the small intestine.  Microbial populations are present throughout the entirety of the 
GI tract, and different gut locations have different populations of microbes reflecting the 
differing environments at each of these locations (Figure 1).  
 The microbial load increases from the oral cavity to the rectum (16).  The oral cavity, 
esophagus, and stomach have relatively few viable microbes per gram contents, and the numbers 
of bacteria gradually increase through the small intestine.  The cecum and colon have the highest 
Figure 1: A Diagram of the swine gastrointestinal tract.  Each gut segment is labeled and the arrows indicate the 
direction of digesta flow. 
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population densities, estimated be upwards of 1011 cells/gram contents, making it one of the 
densest microbial communities known in any environment on the planet (17). Many host factors 
also restrict the amount of microbial growth that occurs in gut segments more proximal than the 
distal ileum, and overgrowth of bacteria before the colon can have negative health consequences 
(18, 19). 
   Several factors impact the distribution of microbes through the GI tract. A pH gradient 
is present,  with the pH being lowest in the stomach (pH = < 2), increasing through the small 
intestine where it reaches neutral or slightly basic pH in the distal ileum (20), and dropping again 
to between 5.5-7.0 in the cecum and colon.  Similarly, an oxygen gradient exists throughout the 
GI tract.  The stomach and its contents are highly oxygenated, with the partial pressure of oxygen 
being only slightly lower than atmospheric conditions (21).  The lumen of the small intestine is 
considered to be aerobic, but in the distal small intestine the concentration of oxygen begins to 
fall.  In the cecum and colon the luminal contents are anaerobic, with the partial pressure of 
oxygen being very low.  Both host and microbial activities are responsible for this gradient.   In 
addition to this longitudinal oxygen gradient, a radial oxygen gradient exists as well . This 
gradient is most pronounced in the cecum and colon.  The mucosal tissues receive a constant 
supply of oxygen from the bloodstream so they remain oxygenated, and it has been demonstrated 
that this oxygen can diffuse into the lumen (22).  Often facultative anaerobes colonize the 
mucosa and take advantage of the available oxygen to utilize respiratory metabolisms (23).   
The host produces a mucus layer that covers nearly all epithelial surfaces in the GI tract, 
creating additional niches for microbial colonization.  The mucus layer serves as the first barrier 
between the outside world and the intestinal mucosa and also helps to lubricate and prevent 
mechanical damage from the food bolus as it moves through the GI tract (24).  This layer is 
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composed of individual mucin proteins that are made of a heavily glycosylated protein core.  
Mucins come in two distinct types: secretory and membrane-bound.  Membrane-bound mucins 
are physically anchored to epithelial cells, while secretory mucins are secreted by specialized 
cells known as goblet cells (24).  These two types of mucins work cooperatively to form a robust 
mucus barrier with the goal of protecting host tissues from environmental insults and invasion by 
commensal bacteria.    
Two distinct mucus layers exist in the gut: a firmly adherent mucus layer directly 
adjacent to the epithelia, and a loosely adherent mucus layer located towards the lumen.  Both of 
these layers are primarily composed of the MUC2 protein and contain many barrier-enhancing 
proteins such as host secreted antimicrobial peptides (AMPs) and secretory IgA (sIgA) (25, 26).  
In healthy animals, the firmly adherent mucus layer is nearly devoid of bacteria, but the loosely 
adherent layer is heavily colonized by diverse populations of microbes (27).  The mucus layer is 
a rich source of carbohydrates for intestinal bacteria; as much as 70% of the weight of the MUC2 
protein is composed of O-linked oligosaccharides, which are a good carbon source for bacteria. 
The loosely adherent layer is generated from the firmly adherent layer as commensal bacteria 
break down sugar linkages and the cores of the MUC2 proteins.  Many different types of bacteria 
harvest host-derived glycans from the mucus layer (28), and this digestion of the mucus layer is 
normal and healthy so long as the rate of mucus degradation does not exceed the rate at which it 
is excreted (29).   The communities of bacteria associated with the mucus layer often differ from 
those in the lumen, reflecting the differing carbon-source availability and differing redox 
potentials (30).  The gradients and differences in environmental conditions throughout the gut 
create unique niches that are filled with a variety of different bacterial species. 
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Biogeography of the intestinal microbiota 
The microbes that colonize each gut location reflect the environmental conditions at these 
locations.  Several surveys of the biogeography (physical distribution species) of the intestinal 
microbiota have been conducted in a variety of animals, and similar trends are detected between 
different species. While the majority of available data is from the human gut microbiome, many 
swine-specific studies have been performed.  Generally, different gut locations have different 
community compositions, but community compositions of gut locations also differ between the 
lumen and mucosa.  The majority of species detected in the gut belong to 4 main phyla, 
Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria (31), and many members of these 
phyla have specifically adapted to the host-associated gastrointestinal environment.  
  Very little diversity is detected in stomach contents, reflecting its harsh environmental 
conditions; however, the stomach is not sterile as once thought.  Species belonging to the genera 
Veillonella, Lactobacillus, and Clostridium have been cultured from gastric juices (32), though 
they are thought to be transient members of the stomach microbiota (33).  The gastric mucosa, 
however, has been shown to have more permanent residents.  Bacteria belonging to the genera 
Lactobacillus, Streptococcus, Veillonella, Prevotella, and Helicobacter have been routinely 
detected in the gastric mucosa through traditional and culture-independent techniques.  A meta-
analysis of swine gut microbiota recently demonstrated that the Lactobacillus and Acinetobacter 
genera are common members of the swine gastric mucosa (34), and an additional study 
suggested that the gastric mucosa can harbor diversity comparable to other GI segments (35). 
In the small intestine, the richness of the bacterial community begins to rise.  Several 
studies of the swine gut microbiota have examined bacterial diversity in the small intestine, 
although very few samples are available for the segments more proximal than the ileum (34).  
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Generally, the microbes that inhabit the ileum belong to the phylum Firmicutes, although 
Proteobacteria are often represented as well (36).  Notably, many studies have shown that the 
phylum Bacteroidetes is not abundant in the ileum, despite being a major phyla elsewhere.  In 
swine, it has been demonstrated that the ileal mucosa harbors significantly more diversity than 
the luminal contents, and it has been postulated that this community may serve as a “seed” 
community for the cecum and colon (36).  Metagenomic investigations of the ileal microbial 
community suggest that this community is not important for the breakdown of complex resistant 
dietary fibers, but rather takes advantage of small molecules such as mono- and disaccharides 
(36, 37).  
Although the microbiota of the ileum may not be crucial for the processing of recalcitrant 
dietary substrates, it has been suggested to be a vital part of the education of the intestinal 
immune system. Swine (as well as humans) have specialized immune structures known as 
Peyer’s patches throughout the small intestine, and these structures are particularly dense in the 
distal ileum (38).  The Peyer’s patch is a structure that is visible by the naked eye and appears as 
a rough, raised area of the intestinal epithelium (39).  These patches are made up of a high 
density of microfold cells (M-cells).  These are specialized structures that are designed to allow 
immune cells to sample antigen from the intestinal lumen (40).  In swine, these structures have 
been shown to be important for the education of various types of immune cells, and antigen 
sampling in these structures can dictate the types of immune responses  to colonizing commensal 
microbes (38).  It follows that the microbes that colonize the ileum and ileal mucosa play an 
important role in the host immune response to commensal organisms. 
 The cecum and colon, also known as the distal gut, are where bacterial activity and 
community densities are highest.  The cecum in swine is a large pouch where vigorous microbial 
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fermentation of dietary fiber occurs.  The bacterial populations that inhabit the cecum are distinct 
from those that inhabit other sections of the GI tract; however, some overlap in species 
composition occurs.  The most notable difference is the increase in the proportion of bacteria 
belonging to the phylum Bacteroidetes in the cecum.  These are Gram-negative anaerobic 
bacteria that are known for their ability to degrade and ferment complex dietary substrates (41).  
In swine the vast majority of species belonging to this phyla belong to the genus Prevotella.  The 
abundance of this genus is likely a direct result of the diets commonly given to commercial 
swine, which are high in carbohydrates (corn) and low in fats and proteins.  Many studies have 
shown that this genus thrives in the hindguts of organisms that consume diets rich in plant 
carbohydrates (42, 43).  In further support of this connection, multiple studies have shown that a 
diet rich in fats and proteins and low in plant-based carbohydrates selects against members of the 
genus Prevotella (43, 44).  
Many other types of anaerobic bacteria are in high abundance in the distal gut.  The 
phylum Spirochaetes is also more abundant in the swine cecum and colon; this is primarily due 
to the abundance of the genus Treponema that has been shown to be common in swine (34).  
Bacteria belonging to the families Ruminococcaceae and Lachnospiraceae similarly increase in 
the distal gut.  Although all of the aforementioned bacterial groups are common members of the 
distal gut of swine, a recent meta-analysis of swine has shown that no species are always found 
in the colon or cecum of every pig (34).  Rather, many diverse bacterial species can thrive in the 
anaerobic environments of the distal gut and feed off of dietary fibers and host-derived 
substrates.  The communities that are present are a result of the dietary substrates available, and 
diet has been shown to be a powerful driver of the community structure of the hind gut (45).    
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  Although all of the bacterial populations at all segments of the GI tract have impacts on 
gut health, the distal gut harbors by far the most microbial diversity and metabolic activity.  The 
interactions between the host and microbiota in the distal gut are essential to host health; some 
even go so far as to call the microbial communities in the distal gut the ‘forgotten organ’ (46).  
Only recently are the functions and interactions of the distal gut microbiota being appreciated for 
the systemic effects they can have on the host (47).  Much of the remainder of this document will 
focus specifically on the microbiota of this gut segment, their functions and activities, the 
interactions between bacterial species and with the host, and how this knowledge can be 
leveraged to benefit host health. 
Functions of the gut microbiota 
Dietary fiber digestion 
In hindgut fermenting animals, the intestinal microbiota are not technically essential for 
the survival of the host. That said, a healthy microbiota performs many important functions, and 
disruptions, or dysbiosis, in the intestinal microbial community can have serious health 
implications.  Germ-free animals of many different species appear normal by most standard 
metrics of health but are much more susceptible to many pathogens because they do not have a 
microbiota to competitively exclude pathogenic invasion (48). Germ-free animals are also not 
able to extract maximal energy from their diets (49).  This is because although most of the easily 
digestible substrates are absorbed by the host in the small intestine, dietary fibers (recalcitrant or 
structural polysaccharides such as chitin, cellulose, pectin, and resistant starches) are typically 
fermented by bacteria in the large intestine (50).  Much of the microbial activity in the distal gut 
is directed at the digestion of complex polysaccharides whether they be of host or dietary origin. 
The ability of the gut microbiota to change in response to changes in the diet allows a large 
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plasticity in the types of fibers that can be digested in the distal gut.  In fact, it has been shown 
that gut bacteria can even gain the ability to breakdown dietary substrates from environmental 
bacteria via horizontal gene transfer (51).    In the process of feeding on dietary fibers, bacteria 
produce many metabolites and compounds, some that are absorbed by the host, and others that 
have impacts on other microbial symbionts.   
Vitamin synthesis 
Many bacterial groups synthesize several different vitamins that are absorbed by the host 
epithelia.  B-group vitamins such as folate and riboflavin are synthesized by well-known 
probiotic strains of Lactobacillus spp. and Bifidobacterium spp. (52).  A recent study suggested 
that the metabolic pathways for B vitamin synthesis are common in human gut metagenomes 
(53).  Similarly, a complementary study of the genomes of common gut bacteria suggested that 
the genes for B-vitamin synthesis are widespread and are found among all phyla (54).   Another 
study has suggested that the host has dedicated systems to absorb microbially produced B-
vitamins in the colon (55), and it has been estimated that up to a quarter of the recommended 
daily intake of several B vitamins can be satisfied by microbial production in the colon alone 
(56).  Similarly, several studies have also shown that vitamin K production by the distal-gut 
microbiota is important and has impacts on host health.  Germ-free rats that were not given 
dietary vitamin K did not have adequate prothrombin levels (an important clotting factor) and 
had clotting disorders, while conventional rats (those with a gut microbiota) did not suffer the 
same adverse consequences of dietary deficiency of vitamin K (57).  Similarly, humans with low 
dietary intake of vitamin K did not suffer deficiencies unless they were treated with broad-
spectrum antibiotics, which depleted their intestinal microbiota (58).   
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Microbial alteration of dietary compounds 
 In some cases, bacteria in the distal gut do not directly create physiologically relevant 
compounds, but rather alter the compounds and therefore alter their effects on the host as well as 
the microbial ecosystem.  One example of this is bile acid modification. Bile acids are released 
by the host to aid in the solubilization and absorption of fats.  The majority of these are re-
absorbed in the distal ileum, but a small amount reach the distal gut where microbes alter their 
structures and activities in a variety of ways.  Bile has important signaling functions in many 
host tissues, and microbial alterations of bile acids alter their signaling capabilities and therefore 
affect the bile-associated signaling networks in host tissues (59).  Additionally, bile has 
antimicrobial effects due in part to its ability to act as a detergent that can disrupt microbial 
membranes; however, these effects can be enhanced after alteration of their molecular structures 
(60).  Many beneficial gut bacteria have intrinsic resistance to the antimicrobial effects of bile 
and this resistance is commonly used to identify potentially beneficial probiotic strains (61). 
 Plant polyphenols, also known as phytochemicals, are an area of active research due to 
their potential associations with health (62).  Although this is a very diverse group of 
compounds, they often share the characteristic of having poor bioavailability, meaning they are 
poorly absorbed by the host in the small intestine and therefore reach the colon.  Once in the 
colon, various microbial activities have been shown to alter the structures of these compounds 
(56).  Once altered, these compounds are more readily absorbed by host tissues and can then 
perform their beneficial actions such as anti-inflammatory activity (63), anti-tumor activity (64), 
or anti-diabetic activity (65).  Currently compounds in this category are being investigated to 
improve various aspects of animal production, including swine (66) 
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Education of the immune system 
 An additional important function of the gut microbiota is the education of the host-
immune system.  “Educating” the immune systems is the training of immune cells in regards to 
which antigens are foreign and which are self, and how to react to these antigens.  The intestinal 
mucosa is the largest region exposed to the outside environment in a mammal based on surface 
area. Therefore, up to 70% of all immune cells reside in gut associated tissues, depending on the 
host species (39).   Disturbances or dysbiosis in the intestinal microbiota have potential 
associations with many auto-immune diseases including allergies, asthma (67), type 1 diabetes, 
multiple sclerosis, rheumatoid arthritis, lupus (68), and other inflammatory disorders (69).  The 
mechanisms and connections between dysbiosis and these diseases are still being clarified but 
current data suggest that the activities of the intestinal microbiota have important consequences 
for immune responses in the gut and in the body. 
Microbial production of short chain fatty acids (SCFAs) 
 The previously mentioned functions of the gut microbiota are certainly important; 
however, the production of SCFAs by microbial fermentation is arguably one of the most 
important.   Most SCFAs are produced by anaerobic fermentation of dietary fiber in the hindgut.  
Some fermentation occurs in the small intestine, but the low microbial biomass and the 
availability of oxygen for respiration limit the amount of SCFAs produced in these gut locations 
(70).  Aerobic respiration also occurs in the distal gut but is a much smaller fraction of the total 
microbial metabolic process than anaerobic fermentation (71).  The main SCFAs produced in the 
hindgut are acetate, propionate, and butyrate, generally occurring in ratios ranging from 75:15:10 
to 40:40:20 (72).  Other SCFAs are produced as well, but they are either produced in small 
quantities (valerate, caproate), or are metabolic intermediates (lactate, succinate) that are quickly 
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converted to other SCFAs (71).  In the colon, SCFA concentrations can reach as high as 200 
mM, although it can be difficult to accurately quantify the total production of SCFAs due to the 
absorption of these compounds by host tissues (73).  
 All SCFAs can be absorbed by host tissues and are utilized in a variety of ways.  The 
colonic epithelia, as well as other cell types, can express several monocarboxylate transporter 
(MCT) proteins, and these are used to import microbial fermentation products from the lumen 
(74).  Various MCT isotypes exist and all known varieties are symporters, which couple the 
transport of SCFA anions to the simultaneous transport of cations such as H+ and Na+ (75).  
SCFAs can also enter host tissues via passive diffusion, although this is of less importance than 
active transport (75).  Once SCFAs have been absorbed, they affect the host in a variety of ways.  
The three main SCFAs (acetate, propionate, and butyrate) can be detected in the portal blood in 
much higher concentrations than peripheral circulation due in large part to extensive processing 
of these compounds by the liver.  Acetate is oxidized in the tricarboxylic acid (TCA) cycle as an 
energy source, but is also used as a biosynthetic building block in the production of fats and 
lipids (49).  Propionate is largely used for gluconeogenesis in the liver (75) although  it has been 
shown that some immune cells use this fatty acid as a fuel as well (76).  Butyrate that reaches the 
liver is mainly oxidized in the TCA cycle much like acetate. However, this fatty acid’s true value 
is realized not in systemic circulation, but very near to the site it is produced: the intestinal 
mucosa. 
Butyrate as a central regulator of intestinal homeostasis 
Butyrate, a four-carbon SCFA, has many well-documented effects on intestinal health.  
As with other SCFAs, butyrate is utilized by the host as an energy source; however, unlike the 
other common SCFAs, butyrate is the preferred energy source for colonocytes (77) and is rapidly 
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absorbed and oxidized by the colonic epithelium.  Beyond its use as a fuel source, butyrate is 
also able to induce transcriptional changes in the host epithelium.  These changes in expression 
generally re-enforce the innate colonic defense barrier.   It has been shown to induce expression 
of antimicrobial peptides and increase their levels in the colonic mucus layer (78).  Similarly, 
butyrate stimulates the production of the MUC2 protein, increasing the secretion and thickness of 
the mucus layer.  Administration of 0.1mM butyrate to human colon biopsies ex vivo was able to 
stimulate mucus production (79).  Tight junction proteins are similarly affected, with butyrate 
causing an increase in their expression and a decrease in the permeability of the colonic epithelia 
(80).  These effects together decrease the likelihood that intestinal microbes will contact host 
immune cells and elicit a response. 
 In addition to its ability to reinforce the colonic epithelial barrier, butyrate exerts potent 
immunomodulatory actions, most of which result in anti-inflammatory effects.  Butyrate has 
been shown to reduce colonic inflammation by limiting the activity of pro-inflammatory CD4+ T 
cells.  Additionally, the same study showed that butyrate also reduced the sensitivity of colonic 
epithelial cells to IFN-γ, a proinflammatory cytokine (81).  Butyrate was recently shown to 
induce the expression of extra-thymic T-regulatory cells.  These are immune cells that are 
involved in promoting tolerance of the commensal microbiota and generally dampen 
inflammatory processes in the gut (82).  Similarly, butyrate has been shown to exert anti-
inflammatory effects on macrophages from the lamina propria.  Macrophages are one of the most 
abundant cell types in the intestinal lamina propria, and exposure of these cells to butyrate 
significantly down regulated their expression of LPS-induced pro-inflammatory mediators, such 
as IL-6 and IL-12 (83).  While maintenance of immune tolerance is complex and requires a 
balance among many regulatory factors, it appears that butyrate is a signal for the host immune 
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system to inhibit pro-inflammatory responses and tolerate the populations of microbes that are 
present (84). 
The role of butyrate in colonization resistance  
 Because of its potent immunomodulatory effects and its role in supporting the physical 
colonic epithelial barrier, butyrate plays a key role in the development of colonization resistance 
to gut pathogens.  Initially it was thought that butyrate and other SCFAs provided colonization 
resistance through pH effects and pH-dependent antimicrobial action (85).  Indeed, increased 
levels of SCFAs have been shown to inhibit the growth of members of the Proteobacteria 
phylum and other pathogens in vitro (86, 87).  However, recently it has been proposed that 
SCFAs and butyrate in particular contribute greatly to colonization resistance by limiting the 
availability of terminal electron acceptors available for microbial respiration.   
Products of the host immune response are one source of compounds that feed microbial 
respiration. When the intestinal immune system mounts an inflammatory response, it releases 
reactive oxygen species such as NO and peroxides.  These in turn cause the generation of NO3 
and tetrathionate, which can serve as terminal electron acceptors in many different species. The 
pathogen Salmonella enterica perfectly demonstrates this phenomenon as it has been shown to 
exhibit chemotaxis toward host-generated electron acceptors (88), and Salmonella spp. genomes 
encode metabolic networks that enable increased growth in the inflamed gut (89).  Butyrate, a 
powerful signal for immune tolerance, reduces inflammatory signaling and the production of 
immune-derived reactive oxygen species (90).  
In addition, it has been shown that the consumption of butyrate by host tissues plays a 
central role in the reduction in mucosal availability of oxygen.  Colonocytes pump water from 
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the lumen of the colon requiring a large amount of ATP (91).  This ATP demand is satisfied via 
the oxidation of butyrate in the TCA cycle, a process which consumes large amounts of oxygen.  
Under normal conditions, so much oxygen is consumed that the colonic epithelia is strongly 
hypoxic.  This limits the diffusion of molecular oxygen from the tissues into the mucus layer 
(92).  It has been demonstrated in mice that depleting the butyrate-producing microbiota with 
antibiotics causes an increase in oxygen concentrations of the colonic mucosa.  This leaves these 
mice susceptible to colonization by mucosal pathogens; however, colonization resistance can be 
restored via oral administration of butyrate (93). 
Under normal colonic conditions, anaerobes can outcompete members of the 
Proteobacteria phylum or other groups capable of respiration, but with the appearance of 
terminal electron acceptors the balance is shifted and the invaders can outcompete the normal 
commensals (90) (Figure 2A and 2B).   Many studies have shown that disturbances (reductions 
in normal commensal bacteria) in the gut are associated with, or followed by, a bloom in 
Proteobacteria species (94-98).  These disturbances are detrimental to the normal function of the 
Figure 2: Interactions between host and commensal bacteria contribute to colonization resistance.  A: Under normal conditions, 
interactions between commensal bacteria and the host, mediated by SCFAs and symbiont associated molecular patterns (SAMPs), 
establish conditions in which invasive members of the Proteobacteria phylum cannot compete and are present only at low levels. B: 
Any disturbance that causes alterations in the ratios of commensal bacteria can lead to reduced SCFA production, (including 
butyrate) causing increased levels of inflammation and oxygenation of the mucosa.  Under these conditions, members of the  
Proteobacteria phylum can begin to utilize respiration and outcompete commensal bacteria.  
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distal gut and host health.  Microbes that produce SCFAs (butyrate in particular) help to maintain 
a colonic environment that excludes pathogens by promoting immunological tolerance and 
maintaining hypoxic conditions in the epithelia, depriving pathogens or other invasive microbes 
of the ability to utilize respiratory metabolisms. 
 
Manipulating the intestinal microbiota to improve host health and resistance to disease 
Probiotics 
Probiotics are live organisms administered to a host with the intent of beneficially 
manipulating the functions or composition of the gut microbiota.  Currently many probiotics are 
commercially available yet, our understanding of manipulating the intestinal ecosystem with live 
organisms is not well developed (99).  Perhaps due to our limited understanding of how these 
administered organisms integrate into the existing intestinal ecosystem, individual responses to 
the same probiotic treatments can vary considerably.  One individual may experience significant 
benefits from a probiotic administration, whereas another individual receiving the same 
treatment may experience nothing (100-102).   This phenomenon is likely due to differences in 
the established microbial communities of each individual, which vary significantly even among 
healthy individuals (3, 34, 103).  It may be necessary to survey the existing community prior to 
probiotic administration and use this information to select an appropriate probiotic candidate for 
each individual (104).   Despite these limitations, administration of probiotics is promising for 
the treatment and prevention of many conditions. 
In swine, probiotics are being used for many applications and are an attractive alternative 
to antibiotics, particularly in newly weaned animals in which the intestinal community has not 
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fully established itself and is susceptible to disturbance and change (105, 106).  Many different 
species and strains of bacteria are being administered, although the most common strains belong 
to the genera Lactobacillus, Bifidobacterium and Bacillus (107).  Organisms of these genera are 
most often used because of their history in association with gut health, their ease of culture, and 
their regulatory status (most are classified as generally recognized as safe (GRAS) and have low 
regulatory hurdles).   Many studies have shown promising results for the oral administration of 
probiotic bacteria in swine (108-110); however their effects are not profound and often variable.  
One study even suggested that administering probiotics at a very high dose can have detrimental 
effects. Lactobacillus rhamnosus administration provided a better outcome in an Escherichia coli 
challenge model, but negative consequences were seen with a high dose (1012 cells/day) (111). 
Investigation of bacteria for probiotic administration is ongoing, and the more recently 
developed probiotic strategies have moved away from the administration of a single strain in 
pure culture.  Using probiotic bacteria to ferment feed prior to ingestion by animals has shown 
great promise, and this strategy gives the probiotic microbes a chance to colonize food particles 
prior to competition with endogenous intestinal microbes (112).  Multi-species probiotic blends 
are being developed (113), and innovations in the mode of delivery are increasing the viability of 
probiotics (114).  Perhaps the most promising advancement is the realization that probiotic 
organisms have a greater chance of colonizing the intestinal tract if they are co-administered with 
the dietary fibers they prefer to consume. 
Prebiotics 
Any dietary fiber that is consumed in the gut by intestinal bacteria can be considered a 
prebiotic.  If a dietary fiber is not digested by the host but is also not consumed by bacteria in the 
gut it is not considered a prebiotic.  Changes in diet have proven the most effective way to 
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change the intestinal microbiota, and so prebiotics are an extremely promising way of pushing 
these communities towards those associated with health (115).  Many common dietary fibers that 
have prebiotic abilities include but are not limited to resistant starches, inulin, xylo-
oligosaccharides, and fructo-oligosaccharides.  These compounds are all complex carbohydrates 
that escape host digestion.  In the case of some of these compounds, such as inulin or xylo-
oligosaccharides, the host lacks the digestive enzymes to cleave the bonds between these various 
sugars.  For others, such as resistant starches, the host technically has the capacity to 
depolymerize and digest the compounds; however, due to the crystal or physical structure many 
of the bonds are inaccessible and consequently the molecules escape digestion (99, 115, 116).   
Prebiotics affect many members of the intestinal microbiota.  The intestinal microbiota is 
a complex tangle of interconnected food webs, and the introduction of a new substrate causes a 
domino effect, changing populations of many interdependent bacterial species.  It has been 
shown that certain keystone species are vital for the initial degradation of some prebiotics. 
Keystone species are those that play an integral role in an ecosystem or ecosystem function, and 
their presence or absence dramatically affects the ability of other species to succeed in that 
particular ecosystem.   In the case of resistant starches, Ruminococcus bromii and various 
Bifidobacteria species have been shown to be keystone species for the degradation of these 
substrates in colonic ecosystems (117, 118). In both of these scenarios, the initial breakdown of 
the resistant starch polymer is followed by an increased abundance of bacteria that consume the 
breakdown products of these keystone degraders.  Often the species that benefit are butyrate-
producers and as such are associated with the health of the host (119).  However, as with 
probiotics, inter-individual variation is also observed in the literature on resistant starch 
supplementation.  One trial suggested that it is the presence of these keystone starch-degrading 
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organisms which dictate if an individual will respond favorably to resistant starch 
supplementation (120). 
Resistant starches have been increasingly used in swine agriculture to increase intestinal 
health and prevent disease.  A recent study has detailed the changes in the swine gut microbiota 
following long-term supplementation of resistant starch and showed an increase in species 
belonging to the genera Lachnospiraceae, Prevotella and Ruminococcus, all of which are 
associated with degradation of dietary fiber, production of SCFAs, and gut health (121).  
Another study administered resistant starches to weaned pigs in varying concentrations and 
observed an increase in species belonging to the genus Bifidobacteria.  This study also suggested 
that the correct dose of resistant starch is critical and too much can have negative consequences 
(122).  Raw potato starch (RPS) is showing increasing promise for mitigating post-weaning 
disorders in piglets, with a recent study showing benefits of administering relatively low 
concentrations (0.5% and 1%) on reducing the incidence of diarrhea (123). 
Conclusions 
 The intestinal microbiota of all animals is an integral part of the host and is tightly 
connected to health. It is critical to understand these microbial ecosystems and their interactions 
with the host in order to develop strategies to maximize resistance to disease.  The work 
described in this thesis represents progress towards these goals.  Tools to study the butyrate-
producing community are outlined and used to investigate this community in the distal gut of 
swine.  A detailed description of a new butyrate-producing bacterial species lays the foundations 
for its potential use as a probiotic.  Raw potato starch’s effects on the gut microbiome and host 
mucosa in weaned pigs are investigated and show promising benefits.  These three studies 
significantly contribute to our goal of increasing knowledge of the swine-gut microbiota and 
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advance our understanding of how to best manipulate these communities to improve host health 
and resistance to disease. 
 
Preview of Chapter 1: Tools to study the butyrate producing community in the gut 
 Because of butyrate’s importance in maintaining colonic homeostasis and host health, 
studying and manipulating the bacterial populations responsible for its production is of great 
interest.  In order to manipulate this community, it is important to understand how butyrate is 
produced in the gut.  Butyrate producers do not form a monophyletic group and at least four 
different biochemical pathways lead to butyrate production.  The cecum and proximal colon are 
considered to be the main sites of butyrate production in hindgut fermenters; in these locations, 
carbohydrates that escaped host absorption serve as the main metabolic inputs.  The most 
common pathway in these environments is referred to as the acetyl-CoA pathway.  This pathway 
entails the condensation of two molecules of acetyl-CoA into aceto-acetyl-CoA, then its 
reduction to crotonyl-CoA and finally butyryl-CoA.   Other amino acid-based pathways may be 
more common in the distal reaches of the colon where fermentable carbohydrates have been 
depleted (124).   
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Once butyryl-CoA has been generated, two main 
mechanisms exist for the final conversion to butyrate.  
The first is through the phosphorylation of butyryl-CoA 
and transformation to butyrate, along with the generation 
of ATP, via butyrate kinase (Buk) (125).  The second 
option, which is much more common in the distal gut, is 
catalyzed by butyryl-CoA: acetate CoA transferase 
(But).  This enzyme takes the CoA group from butyryl-
CoA and transfers it to acetate yielding acetyl-CoA 
(Figure 3).  One of the advantages to using this 
transferase as the terminal gene of the butyrate synthesis 
pathway is that it re-generates the initial input of the 
main butyrate production pathway, acetyl-CoA.  This 
transferase is thought to be especially advantageous in the colonic ecosystem due to the normally 
high levels of acetate, allowing butyrate producers to take up and utilize a waste product 
discarded by other microbes (126).  Studies have suggested that the majority of butyrate 
production in the gut is the product of But enzyme activity (124, 125, 127, 128).   These 
characteristics make the but gene an excellent marker to study the butyrate-producing 
community in colonic environments.  
Using the but gene as a marker for butyrate production is not without challenges.  The 
existence of closely related transferases that have differing substrate preferences (127-129) make 
it difficult to know which sequences represent legitimate But proteins.  Genes encoding 4-
hydroxybutyrate transferases (4hbt) are the sequences most commonly mistaken for but genes; 
Figure 3: A summarized representation of the 
most common pathway for butyrate production 
in gut environments. The gold star depicts But 
enzyme activity. 
A 
B 
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however, acetyl-CoA hydrolases are often confused as well.  Automatic annotation algorithms 
cannot accurately distinguish between these groups, leading to frequent misannotation of these 
genes in both genomic and metagenomic datasets (128).  Preliminary data suggest that many 
genomes contain two very similar genes, one that is a verified but gene sequence and one that is 
a closely related transferase but has different substrate specificities and activities.  In these cases 
both genes have very similar conserved regions and are annotated similarly.  Unfortunately, 
because of the existence of these highly conserved regions in related transferases, it is possible 
that when using degenerate primers non-but genes may be amplified along with actual but genes.  
To improve the quality of but gene sequence datasets and the automatic annotations of genomes 
and metagenomes, more research is needed to accurately describe but genes and discriminate 
them from closely related sequences.   
This chapter describes the functional characterization of several butyryl-Coa:acetate 
CoA-transferases from butyrate-producing bacteria isolated from the swine intestinal microbiota.  
Characterization of these genes' functions and substrate specificities show that functionally-
confirmed but genes and paralogues exist in the same genome in several species.  This functional 
information is used to identify a discriminating motif between these two groups and this 
knowledge is used to design a degenerate primer set that preferentially amplifies functional but 
genes over their paralogues.  This primer set detects a large number of phylogenetically diverse 
butyrate producers, but also has significant biases.  Finally, this primer set is used to perform 
high-throughput culture-independent surveys of the butyrate-producing community. This work 
has been published in the journal Applied and Environmental Microbiology under the title, 
"Function and Phylogeny of Bacterial Butyryl Coenzyme A:Acetate Transferases and Their 
Diversity in the Proximal Colon of Swine". 
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Preview of Chapter 2: Characterization of a butyrate-producing bacterium from the swine 
intestinal tract and initial evaluations for suitability as a probiotic 
Butyrate production is a trait that is found in many different species of bacteria that fill 
many different ecological niches.  Understanding the ecological niches of butyrate-producing 
bacteria is necessary to manipulate these populations for gut health.  Evidence suggests that 
butyrate-producing bacteria shift their metabolisms, and therefore butyrate production, in 
response to changing environmental conditions and cohabitating microbes (130). For example, 
many butyrate producers, such as Roseburia sp., expel hydrogen gas as a waste product (131). If 
the partial pressure of hydrogen gets too high this can cause their metabolism to stall, leading to 
reduced butyrate production. Hydrogen uptake by methanogenic archaea, such as 
Methanobrevibacter smithii, can lower the partial pressure so that microbial fermentation can 
occur at optimal efficiency (132). Additionally, some microbes, such as Megasphaera elsdenii 
and Anaerostipes caccae, produce butyrate by utilizing lactate from other species and have been 
shown to increase their butyrate production in co-culture with lactate producers such as 
Bifidobacteria sp. (133-135).  Furthermore, evidence indicates that when butyrate producers 
associate with hydrogen-consuming acetogenic bacteria, the butyrate output of the system 
increases, such as with the interaction between Roseburia intestinalis and Ruminococcus 
hydrogenotrophicus (136). If a bacterial strain is to be used as a probiotic, it is critical to 
understand it metabolism and potential interactions such as those mentioned above.  Only by 
understanding the ecological context in which butyrate producers exist can strategies be 
developed to ensure their survival and colonization of the host when administered as a probiotic. 
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Detailed biochemical and genomic characterizations of bacterial species are the first step 
in this process. Chapter 2 outlines the description of a new species of bacteria belonging to the 
genus Butyricicoccus and provides a detailed assessment on its required culture conditions and 
growth characteristics.  As part of this analysis a draft genome for this strain has been published 
and leveraged to improve our understanding of this species and postulate its ecological niche. 
Finally, this chapter makes some initial assessments of this Butyricicoccus strain’s (BB10) 
suitability as a probiotic and potential benefits to the swine host.  This work is currently under 
review in the journal International Journal of Systematic and Evolutionary Microbiology. 
 
Preview of chapter 3: Fueling beneficial host-microbe interactions with raw potato starch 
Piglets face a large number of stressors directly after weaning.  Weaned piglets 
experience an abrupt diet change, and their microbial communities must rapidly adapt.  During 
this transition, many of the benefits provided by a healthy microbial community are in flux, and 
this disturbed microbiota in turn reduces colonization resistance.  Piglets with a microbiota better 
adapted to the new diet experience better health and performance outcomes (increased weight 
gain, reduced colonization of opportunistic pathogens) (137).  Intestinal distresses such as post-
weaning diarrhea are common during this transition, and antibiotics are routinely used to combat 
these disorders (138).  However, concerns about the rise of antimicrobial resistance and 
increased regulation of these compounds necessitate the development of alternative treatments 
for these issues. Prebiotics such as raw potato starch (RPS) are emerging as promising solutions 
to intestinal disorders.  
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 RPS is a type 2 resistant starch and has shown great promise as an effective prebiotic. It 
escapes host digestion by virtue of its large crystalline structure, rendering it physically 
inaccessible  to host enzymes for degrading the glycosidic bonds (139).  Once RPS reaches the 
distal gut it is rapidly fermented by commensal bacteria, and its fermentation has been shown to 
have a strong butyriogenic effect.  RPS is currently being used in some swine production 
systems, although determining its optimal dosage, mechanism of action, and optimum age 
administration requires further work. 
This chapter outlines the weaning-associated changes in the community composition and 
functional capabilities of the piglet microbiota.  This work shows that dietary RPS can induce 
beneficial changes in the community composition and functions of the swine gut microbiota as 
well as its interactions with the host.  This work investigates the bacterial food webs responsible 
for the conversion of RPS to beneficial SCFAs such as butyrate, and suggests that RPS intake is 
associated with many markers of improved gut health.  This study greatly enhances our 
knowledge of the mechanisms through which RPS is converted to beneficial metabolites and 
how these metabolites affect host tissues.  This work additionally identified microbial species 
which can be administered with RPS to enhance its effects in the weaned piglet.   
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Abstract 
Studying the host-associated butyrate-producing bacterial community is important 
because butyrate is essential for colonic homeostasis and gut health.  Previous research has 
identified the gene encoding butyryl-CoA:acetate transferase (2.3.8.3) as a gene of primary 
importance for butyrate production in intestinal ecosystems; however, this gene family (but) 
remains poorly defined.  We developed tools for the analysis of butyrate-producing bacteria 
based on twelve putative but genes identified in the genomes of nine butyrate-producing bacteria 
obtained from the swine intestinal tract.  Functional analyses revealed that eight of these But 
proteins had strong But enzyme activity.  When but paralogues were found within a genome, 
only one gene per genome encoded strong activity, with the exception of one strain in which no 
gene encoded strong But activity.  Degenerate primers were designed to amplify the functional 
but genes and were tested by amplifying environmental but sequences from DNA and RNA 
extracted from swine colonic contents.  The results show diverse but sequences from swine-
associated butyrate-producing bacteria, most of which clustered near functionally confirmed 
sequences.  Here we describe tools and a framework that allow the bacterial butyrate-producing 
community to be profiled in the context of animal health and disease. 
Importance 
 Butyrate is a compound produced by the microbiota in the intestinal tracts of animals.  
This compound is of critical importance for intestinal health, however, there is still much to 
discover about the bacteria that produce it.  Here we present an additional way to study the 
butyrate-producing community of bacteria.  This work will enable researchers to more easily 
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study this very important bacterial function that has implications for host health and resistance to 
disease. 
Introduction 
 Short-chain fatty acids (SCFAs) play a central role in the maintenance of colonic 
homeostasis, which is the delicate balance between the host, its immune system, and the 
gastrointestinal microbial partners (1).  Butyrate in particular has potent effects on host tissues.  
As with other SCFAs, butyrate is consumed by the host as an energy source; however, unlike the 
other common SCFAs, such as propionate and acetate, butyrate is the preferred energy source for 
colonocytes (2) and is rapidly absorbed and used by the colonic epithelium.  This rapid oxidation 
of butyrate reduces local oxygen concentrations, causing the epithelia to become hypoxic and 
thus limiting the growth of facultative aerobic pathogens such as Salmonella (3, 4).  In addition, 
butyrate alters host gene expression for promotion of immune tolerance to the colonic microbiota 
and to improve the barrier function of the colonic epithelium.  For example, butyrate has been 
shown to increase the secretion of antimicrobial peptides and mucus as well as the expression of 
tight junction proteins, thickening and strengthening the barrier while making it less hospitable to 
invasive microbes (5-7).  Most of butyrate’s immunomodulatory activities result in anti-
inflammatory effects, including the production of extra-thymic T-regulatory (T-reg) cells (8), the 
limitation of pro-inflammatory CD4+ T cell activity (9), the stimulation of epithelial cells to 
produce retinoic acid (10),  and the desensitization of colonic epithelial cells to IFN-γ (11).  
Although maintenance of immune tolerance is complex and requires a balance among many 
regulatory factors, butyrate is a major signal for the host immune system leading to inhibition of 
pro-inflammatory responses and to toleration of microbes that are present (12). 
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Because of butyrate’s importance in maintaining colonic homeostasis and host health, 
characterizing and manipulating the bacterial populations responsible for its production is of 
great interest.  Butyrate-producing bacteria do not form a monophyletic group, and at least four 
different fermentation pathways lead to butyrate production (13).  The most common pathway 
for butyrate production in colonic environments entails the condensation of two molecules of 
acetyl-CoA followed by reduction to butyryl-CoA.  After butyryl-CoA has been generated, two 
different enzymes are responsible for the final conversion to butyrate: butyrate kinase (Buk), and 
butyryl-CoA: acetate CoA transferase (But) (14), with the But protein being the most common in 
the colonic environment (13). This enzyme takes the CoA group from butyryl-CoA and transfers 
it to acetate yielding acetyl-CoA, thus re-generating a substrate of the main butyrate production 
pathway.  This transferase is thought to be especially advantageous in the colonic ecosystem due 
to the high levels of acetate, allowing butyrate producers to take up and use a waste product of 
other microbes (15).  Many studies have suggested that the majority of butyrate production in 
hindgut fermenters is the product of But enzyme activity, including in swine (13, 14, 16-18).   It 
should be noted that previous work has suggested not all enzymes capable of But activity are 
homologous.  Previous work demonstrated that some bacteria from clostridial cluster XVI 
isolated from the chicken cecum had But activity despite lacking genes with significant 
homology to the but gene family (19).  The authors identified genes similar to other known 
propionyl-CoA transferases in these genomes and suggested that these genes were responsible 
for the observed But activity.  This work focuses only on genes encoding But enzymes 
commonly found in the Ruminococcaceae and Lachnospiracea families (previously known as 
clostridial clusters IV and XIVa), and is not applicable to But-active enzymes with different 
evolutionary origins.    
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The sequence variation for the but gene family is poorly defined and currently includes 
closely related transferases that have differing substrate preferences (16, 17, 20).  The FunGene 
But-protein database is a large repository of But-like protein sequences and is an excellent 
resource; however, it contains But proteins and similar transferases that have distinct substrate 
specificities.  Furthermore, few But proteins in this database have been functionally confirmed.   
Here we have analyzed the but gene from previously identified butyrate-producing bacteria from 
swine (18), defined the functional diversity of the but sequences, developed degenerate but 
primers for PCR, and investigated the butyrate-producing bacterial community in the swine 
colonic environment.  The results show that the degenerate but primers preferentially amplify 
genes encoding functional But enzymes over their paralogues, and that diverse but genes are 
transcribed in the swine colon.    
Methods 
Identifying potential but-encoding sequences 
Previous work identified nine strains of swine-associated intestinal bacteria as butyrate 
producers as determined by gas chromatography.  Additionally, these strains were also found to 
exhibit But activity although the active genes could not be identified in all cases (18). These 
strains were subjected to shotgun genomic sequencing to identify the genes encoding their But 
activity.  Genomic DNAs were isolated using a previously described protocol (21).  Sequencing 
was performed using a HiSeq 2500 sequencer (2 x 150 bp, rapid mode; Illumina, San Diego, 
CA) or a MiSeq (2 x 300 bp) at the Iowa State University Office of Biotechnology (DNA 
facility, Ames, IA), and a Pacific Biosciences sequencer (P6-C4 chemistry; PacBio, Menlo Park, 
CA) at the Yale Center for Genome Analysis (New Haven, CT), and Roche FLX-Titanium 
chemistry (Roche Diagnostics, Branford, CT, USA).  Libraries were prepared according to 
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manufacturer’s directions.  The resulting data included some combination of PacBio reads, 
Roche FLX 2.3-kb mate-pair library reads, and Illumina 7.9-kb mate-pair library reads.  These 
were assembled using the MIRA assembler in a de novo hybrid assembly (22).  Potential but 
genes were identified in the genomes by performing a BLAST search with the amino acid 
sequence of the butyryl-CoA:acetate CoA-transferase gene from Roseburia intestinalis L1-82 
(Genbank accession: EEV00989). 
Testing for butyrate transferase activity 
 Candidate genes were cloned into the pET-TOPO-101 vector (Invitrogen, Carlsbad, CA) 
and transformed into TOP-10 E. coli chemically competent cells following the manufacturer’s 
instructions, (primers used for cloning are listed in supplementary table 1).  Plasmid DNAs were 
isolated using the MinElute miniprep kit (Qiagen, Valencia, California), and positive clones were 
confirmed to have full-length gene inserts by sequencing on an Applied Biosystems 3730xl DNA 
Analyzer (DNA facility, Iowa State University, Ames, IA).  Cloned DNAs were additionally 
transformed into BL-21 star competent cells for protein expression, in accordance with the kit 
protocol.  Cultures (100 mL) were grown for 12 hours in LB containing 50 µg/mL carbenicillin.  
Expression was induced by adding IPTG to a final concentration of 1 mM.  After an additional 6 
hours of growth, cultures were harvested by centrifugation, washed, and resuspended in 10mL 
sterile PBS.  Cells were lysed by two passages through a French press (AMINCO, Silver Spring, 
MD).  Lysates were centrifuged at 19,000x g for 10 minutes to remove remaining unlysed cells.  
Protein expression was confirmed and the amount of recombinant protein in each lysate was 
estimated by running 15 µg total protein (determined by Bradford assay, (23)) in a 15% SDS-
PAGE gel, staining with Coomassie-blue, and comparing the 49kD band to all bands in the 
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sample using a densitometry analysis in the ImageJ software package (24).  Activities were 
normalized to the amount of protein present in the 49 kD band. 
 Butyryl CoA-transferase (EC 2.8.3.8) activity was tested using the citrate synthase assay 
as described (16), and activity was measured with acetate and butyryl-CoA as substrates 
(Sigma).  The acetyl-CoA generated by butyrate transferase is condensed with oxaloacetate, 
liberating CoASH, which reacts with 5,5'-dithio-bis-(2-nitrobenzoate) to form a yellow 
thiophenolate anion.  The reaction rates were measured by monitoring the absorbance at 412 nm 
at 39°C on a Beckman DU-650 spectrophotometer (Indianapolis, IN).  Crude cell lysates were 
diluted with sterile water as necessary to achieve the linear range for the rate of the reaction.  The 
reaction was repeated in the absence of acetate to confirm the measured rate was not due to CoA-
hydrolase activity.   
Designing and validating conserved primers to but   
All full-length, functionally validated but-like genes were aligned using CLC genomics 
workbench (Aarhus, Denmark), and conserved regions were identified.  Degenerate primers 
(funbut-FWD, 5': CARYTIGGIATYGGIGGIATSCC; funbut-REV, 5': 
TGTCCGCCIGYICCRSWRAT) were designed to preferentially amplify those but genes with 
confirmed activity.    
Full-length genes were downloaded from the FunGene but database on March 21, 2016, 
including only those sequences with a score of 275 or higher (25), resulting in 1144 full-length 
sequences after removing redundant entries.  The number of mismatches between the funbut 
primers and each gene in this dataset was calculated with a Python script utilizing the Biopython 
libraries (26) (Supplementary Table 1).  Previously published primer sets from Flint et al. and 
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Vital et al. were also analyzed for comparison (17, 20).  This script yielded a table listing the 
number of mismatches to each primer set for each gene entry.  Fasttree (27) was used to generate 
a phylogenetic tree from full-length amino acid sequences, and the R packages APE (28) and 
ggtree (29)  were used to generate primer coverage figures.  Sequences considered likely to 
amplify were those with two or fewer total mismatches to the primers.    
To investigate potential amplification biases, the funbut primers were used in qPCR 
assays to determine which genes are preferentially amplified.  Full-length gene amplicons were 
generated for each gene included in this study (see table 2 for primer sequences).  The amplicons 
were evaluated via Nanodrop (30) and diluted in 2 µg/mL sheared salmon sperm DNA to 107 
copies/µL.  The qPCR reactions were conducted with the Power SYBR Green PCR Master Mix 
(Applied Biosystems, Foster City, CA) containing each of the funbut primers at 500 nM and 1 
µL but gene amplicon DNA in 20 µl on a Stratagene 3005P thermocycler (San Diego, CA). 
Cycling conditions were as follows: 95° C for 30 seconds, 53° C for 30 seconds, 72° for 30 
seconds, 40 cycles total. Inferences about amplification preference were made by comparing Ct 
values for each gene.  As each reaction contained the exact same primer concentrations and 
numbers of target molecules, any difference in the Ct values among the different targets is due to 
amplification preferences. 
MiSeq but amplicon library prep 
Swine proximal colon contents (10 cm distal from the cecum) were immediately placed 
in RNALater and quickly homogenized to preserve the integrity of nucleic acids.  Samples were 
subsequently frozen at -80°C until extraction (within one month).  DNAs and RNAs were 
extracted using the PowerClean DNA and RNA extraction kits (Mo Bio, Carlsbad, CA) from 
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proximal colon contents from six pigs fed a standard diet and associated with a different study 
(Kumar et al., in review).  The iScript Select kit (Bio-Rad, Hercules, CA) was used to generate 
cDNA from the RNA using random hexamer primers.  Amplicon sequencing libraries were 
prepared following Illumina’s 16S Metagenomic Sequencing Library Preparation (Part # 
15044223 Rev. B) substituting the funbut primers for the 16S primers. This protocol uses a 2-
step PCR procedure: the first step generates the amplicons from environmental samples, and the 
second step adds the indices and the sequencing adapters. In the first step, the funbut primers 
were used to amplify a 359 bp fragment using the AccuPrime Taq High Fidelity PCR system 
(Invitrogen). Due to the inclusion of multiple inosine bases, we were unable to produce PCR 
product using a proofreading polymerase alone (31, 32) necessitating the use of a procedure that 
included Taq as well.  The first-step PCR reactions contained each primer at 500 nM, 100 ng of 
template and used an annealing temperature of 53°C for 35 cycles.  The second PCR step was 
performed in accordance with the protocol using KAPA hifi polymerase (KAPA Biosystems, 
Wilmington, MA) and the Nextera XT v2 indices (Illumina).  This library was sequenced on a 
MiSeq using a 2x300 V3 reagent kit to generate 300 bp paired-end reads. 
Sequence analysis 
Sequences were processed using mothur (33) following a modified version of the ‘Miseq 
SOP’ (http://www.mothur.org/wiki/MiSeq_SOP).  Paired-end reads were joined, quality-
screened, and aligned to full-length high quality but genes downloaded from Fungene as 
previously mentioned.  Sequences passing quality filters were clustered at a 97% similarity 
cutoff and representative sequences were obtained for each operational taxonomic unit (OTU).  
These representatives were used in a BLASTn search against a database comprised of full-length 
sequences from the FunGene but gene dataset plus genes from the current work, to determine the 
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closest matching published sequence (% identity).  Communities were subsampled to 1,556 
sequences per sample prior to further analysis.  Sequences used as references in the phylogenetic 
trees have had their activities confirmed either in this work or in previously published work.   
Genes from human strains have been cloned and their activities confirmed in work such as (16, 
34). Other work has tested crude cell lysates for But enzyme activity such as (15), and inferred 
but gene presence by measuring butyrate production, acetate consumption and the presence of a 
gene homologous to confirmed but gene sequences.  Additionally, reviews such as (35), identify 
isolates with confirmed But enzyme activity.  These reference sequences were trimmed to the 
length of the representative sequences for the OTUs and used to generate a maximum likelihood 
tree using RAxML (36). 
 
Data deposition 
 Bacterial genomes, butyrate transferase sequences and amplicon sequencing data were 
deposited in Genbank under Bioproject PRJNA341691.  The code and data used to generate the 
figures in this paper are available at https://github.com/Jtrachsel/AEM-funbuts. 
Results 
Activity encoded by the but gene is associated with an amino acid sequence motif 
Putative But-encoding genes were identified in the genomic sequence data from the 
butyrate-producing bacteria isolated from swine.  All of the nine genomes analyzed yielded at 
least one potential but gene, and three genomes were predicted to contain two (Megasphaera, 
Butyricicoccus, and Eubacterium), resulting in a total of 12 putative But-encoding genes.  
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Functional analyses revealed that eight genes encoded strong But activity ranging from 7,004 
µM/mg*min (strain 27-5-10) to 27,819 µM/mg*min (strain 831b; Table 1).  Only one but gene 
per genome showed appreciable activity, with the exception of the Eubacterium (strain 68-5-10) 
in which neither putative But protein was highly active (Table 1).  This lack of appreciable But 
activity in strain 68-5-10 is consistent with previous work with this strain using native whole cell 
lysate in the same assay (18).  All genes that showed strong activity also exhibited similar 
activity when propionyl-CoA was used as a substrate (Table 1).  These results are in agreement 
with previous characterizations of this gene family (16) and demonstrate that these sequences 
encode But activity. 
 
 
 
4
9
 
 
Table 1: But enzyme kinetics and amino acid analyses.  Sequences with strong activity are shown in bold with grey shading.  
Strain of 
origin 
 Closest related species (16S BLAST 
identity) 
Gene name 
Length 
(AA) 
crude activity (µM/min*mg)   
Similarity to Roseburia query 
sequence (AA) 
Butyryl-CoA Propionyl-CoA   %id  %pos 
68-3-10 Eubacterium nodatum (93%) 68-3-10 #1 460 77.3 406.4  47 66 
68-3-10 Eubacterium nodatum (93%) 68-3-10 #2 452 218.1 335.4  48 69 
1161 Megasphaera elsdenii LC-1 (99%) Megasphaera 1 441 655.5 637.2  55 69 
1161 Megasphaera elsdenii LC-1 (99%) Megasphaera 2 448 23515.6 20747.3   49 69 
BB10 Butyricicoccus pullaceacorum (92%) Butyricicoccus 1 445 231.2 785.4  48 67 
BB10 
Butyricicoccus pullaceacorum 
(92%) 
Butiricicoccus 2 447 13367.9 12665.3   73 85 
35-6-1  Peptoniphilus grossensis (97%) 36-5-1 447 18343.5 13495.2   62 76 
27-5-10 
Intestimonas butyriciprudecens 
(99%) 
27-5-10 447 7004.6 5725.3   72 85 
494a Anaerostipes butyraticus (96%) 494a 446 13692.3 12767.3   74 85 
992a Anaerostipes hadrus (95%) 992a 446 16152.8 12193.9   77 85 
499 Roseburia hominis (96%) 499 446 8276.8 7946.9   83 91 
831b Roseburia hominis (97%) 831b 446 27819.8 27892.9   86 91 
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To determine sequence motifs associated with active But proteins, an amino acid 
alignment of all 12 putative But proteins was generated.  The alignment yielded several 
differences that demarked those with activity from those without.  These differences occurred in 
a conserved region containing the amino acid motif LQLGIGG (Figure 1).  This motif was 
identical in all highly active But proteins; however, the proteins with low But activity contained 
at least one substitution in this motif.  These data suggested that primers annealing to the nucleic 
acids encoding this site could be 
designed to preferentially amplify genes 
similar to those with high But activity, 
thus distinguishing genes with potential 
But activity from non-functional 
paralogues.  The reverse primer-binding 
site was nondiscriminating since we 
designed it to a gene region where But 
and But-like proteins shared similar 
amino acid residues.  Unfortunately no 
suitable alternative reverse primer-
binding site would preferentially amplify 
all functional genes and still allow a 
primer of reasonable degeneracy for 
amplification. 
 
Figure 1: An amino acid alignment of the primer-binding 
regions. Residue numbering is based on the full length 
But protein sequence from Roseburia intestinalis L1-82 
Genbank accession EEV00989.  Functionally confirmed 
sequences occupy the top green-bordered box.  
Sequences with little activity are bordered by the red 
box.  The glycine at position 234 of this alignment is 
conserved in all highly active sequences. 
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Degenerate primers preferentially target function-associated But protein-coding sequences 
and amplify diverse swine-associated but genes 
 An in-silico analysis compared the primer coverage of currently available but-targeting 
primer sets to the funbut primer pair and revealed that the funbut primers preferentially cover the 
clade containing all functionally confirmed sequences while having little coverage outside of this 
clade (Figure 2).  The funbut primers are likely to amplify (two or fewer mismatches) 194 
sequences, with 95% of these (184 sequences) in the main functional clade of interest.  In 
contrast, the primers published by Vital et al. (17) are likely to amplify 517 sequences, 228 of 
these being in the clade of interest (44%).  Finally, the primers published by Flint et. al. (20) are 
likely to amplify 5 sequences, all of which are in the main functional clade.  It should be noted 
that the estimates for the number of sequences likely to be amplified are based only on the 
number of mismatches; amplification conditions also play a large role.  Each of these primer sets 
could amplify more or less diversity than our estimate suggests depending on the exact 
Figure 2: Primer coverage for the three available but-targeting primer sets.  A: Flint et al. (2), B: 
Vital et al. (3), C: funbut primers.   Maximum-likelihood trees of full-length protein coding sequences 
from the Fungene but database, with the tips of each branch colored to reflect the total number of 
mismatches each primer set has to that particular sequence (red to green).  The clade containing all 
verified but genes is shaded grey.  Sequences with confirmed activity are marked with a blue triangle, 
and but paralogues are marked with yellow triangles. 
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conditions of the PCR reaction. These 
results show that the funbut primers are 
more specific to diverse genes encoding 
functional Buts than are previously 
published but primers.  
The in silico validation of the 
funbut primers suggests that they will 
preferentially amplify functional but 
genes over their paralogues, and to verify 
these findings we investigated the amplification preference of our primers for the functionally 
validated But-encoding genes in this study. The funbut primers preferentially amplified 
sequences associated with But enzyme function over sequences associated with little or no But 
enzyme activity (Figure 3).  However, some but genes were amplified in fewer qPCR cycles and 
therefore more readily than others, revealing amplification biases even among the functionally 
confirmed genes (Figure 3).  
 
A large, unexplored diversity of but genes exists in the swine hindgut 
The funbut primers were applied to nucleic acids from a gut microbial community to 
evaluate but gene detection in this ecosystem.  Diverse but genes were amplified from total DNA 
Figure 3: qPCR Ct values using the funbut primers against 
each gene identified in this study at 107 target molecules 
per reaction.   Genes with lower Ct values are preferentially 
amplified over those with higher Ct values.  NTC, no 
template control  
53 
 
 
and RNA from swine proximal colonic 
contents.   The colonic contents of six pigs 
yielded 90 OTUs from total DNA and 86 
OTUs from total RNA (92 total unique 
OTUs, 97% similarity).  Several OTUs 
were present in all animals, but these OTUs 
differed depending on which nucleic acid 
was used to profile the community.  14 
OTUs were detected in RNA libraries from every pig, four OTUs were detected in all DNA 
libraries, and three OTUs were detected in every library regardless of nucleic acid type (OTU4, 
OTU14, and OTU23).  The RNA-based 
communities harbored a greater diversity of but 
sequences, and these communities were more 
even when compared with the DNA-based 
communities from the same sample (Figure 4; 
Shannon diversity index: Wilcoxon paired, 
p=0.03; Shannon evenness: Wilcoxon paired, 
p=0.03).  Similarly, community membership 
tended to differ between the RNA and DNA-
based communities (Figure 5), suggesting that the 
most active butyrate producers may not be the most abundant. 
Figure 4:  Shannon diversity and evenness indices of 
DNA and RNA but gene sequences, with communities 
from the same animal joined by a dotted line. 
Figure 5: Non-metric multidimensional scaling 
plot of Sorenson dissimilarity distances 
(membership) of the but gene sequence 
communities from six swine colons. Communities 
from the same animal are joined with a dotted 
line. 
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   Representative sequences of many of the OTUs differed greatly from previously 
known, cultured butyrate producers, and some showed more similarity to but genes from 
organisms only detected in metagenomes (Figure 6).  In total, 33 out of 92 OTUs were 
represented by sequences that most closely matched organisms only detected in metagenomic 
datasets.  Similarly, many OTUs were represented by sequences with relatively low identity to 
any previously detected but gene.  The maximum identity detected was 100% and the minimum 
Figure 6: Twenty-five most abundant OTUs, clustered at 97% similarity at the DNA level.  OTU designations 
are followed by the names of the genomes containing the top homologues of representative sequences for each 
cluster, followed by percent identity (top BLAST hit).   Asterisks denote genomes assembled from fecal 
metagenomes. Target sequences for this BLAST search were from the FunGene but gene database as well as the 
genes identified in this work. 
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was 71.2% (OTU4). Representative sequences from 82 OTUs showed < 90% identity, and 23 
showed <80% identity to previously detected genes in the reference databases, whether they 
were of metagenomic origin or not.  These findings suggest that many as-yet-uncultured 
butyrate-producers exist in the swine gut and that this community is underrepresented in 
databases.  Furthermore, the abundances of many OTUs from the same animal differed greatly 
depending on whether gene copy abundance (DNA) or transcript copy abundance (RNA) was 
considered (Figure 6), supporting the idea that the transcriptionally active population is distinct 
from the most abundant.  
  
Predicting function from phylogenetic analysis of But protein sequences 
The genes encoding highly functional But proteins are phylogenetically separated from 
potential paralogues, but this separation is not perfect (Figure 7), with some verified But 
enzymes and potential paralogues occupying the same clades on the tree.  An example of this is 
the Megasphaera #2 gene, which encoded stronger But enzyme activity than the paralogue 
Megasphaera #1 gene from the same genome but was more divergent from the large functional 
clade than other sequences with confirmed activity.  Phylogenetic placement was used to 
determine whether the OTUs detected by the funbut primer set encoded highly functional But 
enzymes or paralogues with lower activity.  The representative DNA sequence from each OTU 
was aligned with confirmed but DNA sequences from the literature and this work (trimmed to 
the amplicon length), and a maximum likelihood phylogenetic tree was constructed from this 
alignment (Figure 8).  Similar to the tree constructed with full-length sequences, most of the 
confirmed reference sequences grouped together in one main clade apart from potential but 
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paralogues, with the Megasphaera #2 gene being the exception.  The vast majority of the OTUs 
detected by the funbut primers clustered more closely with but sequences encoding highly-active 
enzymes than with sequences encoding low activity.  Out of 18,672 total sequences, 18,559 
(99.4%) were contained within OTUs in the main functional clade while only 113 (0.6%) were 
outside this clade near potential but paralogues.   The results suggest that phylogenetic 
relatedness is predictive of function for the majority of but gene sequences and that the funbut 
primers preferentially amplify functional but genes. However, function is more difficult to 
predict for distantly related, deeply branching sequences within the but gene family.  
Figure 7: Maximum likelihood tree containing full-length protein-coding sequences.  Sequences with 
confirmed function are shown in green, and potential paralogues are shown in red.  Note how functional But-
encoding sequences are interspersed with paralogues towards the root of the tree. 
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Figure 8: A phylogenetic tree (maximum likelihood) of representative sequences from OTUs from this study, 
and previously studied But-like sequences identified in Vital et al., 2014 (1). OTUs were generated at 97% 
similarity with the funbut primers.  Sequences with confirmed But enzyme activity are shown in green, and 
sequences that have failed to demonstrate activity in functional assays are shown in red. Numbers at the nodes 
are bootstrap values after 1000 resamplings.  The main clade containing all functionally confirmed reference 
sequences is shaded green, the clade containing both confirmed But-encoding genes and potential paralogues is 
shaded yellow, the clade containing only potential paralogues with low activity is shaded red.  Reference 
sequences from humans are marked with an H, and those from swine with an S. 
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Discussion 
Butyrate is centrally important to colonic homeostasis and is present in every vertebrate 
gut system studied to date (37).  The butyrate-producing microbiota has been implicated in host 
health in many different disease models (38-48), resulting in increased interest in studying this 
community.  It is therefore important to have a reliable tool to identify butyrate-producing 
microbes and to detect their activity.   The but gene is an excellent candidate for this probe due to 
its ubiquity in colonic environments, and we show the rational design of a primer set that detects 
but genes associated with butyrate transferase function. However, any analysis of the butyrate-
producing community that only examines the but gene cannot be considered exhaustive. The 
bacterial butyrate synthesis pathway can be completed by other proteins such as Buk and Ato, as 
well as non-homologous enzymes capable of But activity (13, 19, 49).  Characterizing a wide 
variety of functional genes is a critical step necessary to design targeted primers and probes.  
These data are additionally valuable when conducting comparative analyses of amplicon and 
metagenomic datasets from gut bacterial communities under different conditions.   
Comparison of currently available but primer sets 
Several primer sets targeting the but gene are currently available.  The first was described 
by Flint et al. in 2007 (20).  This primer set was designed to be used in qPCR assays to estimate 
the total number of but gene copies in complex environments such as feces.  Much care was 
taken to avoid any amplification of non-target, closely related transferases, resulting in a 
conservative primer set.  These primers are unlikely to amplify paralogues of the but gene, but 
also miss much of the full diversity of functionally verified gene products.  Due to the specificity 
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of these primers, very little spurious amplification is observed when used on complex samples 
such as feces.  
Conversely, Vital et al. recently described a more promiscuous set of but primers (17).  
These primers were designed to amplify a wide range of but-like sequences, acknowledging that 
they would amplify closely related non-but genes.  The primers were used to elucidate the 
diversity of but gene sequences in humans and many other vertebrate species via Roche’s 454 
pyrosequencing (17, 37).   The in silico processing pipeline they describe attempts to remove 
some of the non-but sequences by eliminating those that closely match reference sequences that 
reside outside of the phylogenetic cluster formed by functionally confirmed But-encoding genes.  
This method, while useful, is imperfect; the functional validation of but gene family members 
presented here has revealed that the phylogenetic separation of verified But-encoding genes and 
their paralogues is not absolute (Figures 7,8).    Additionally, because of the degeneracy of this 
primer set, spurious off-target amplification and incorrectly sized PCR products regularly occurs 
with these primers, necessitating the inclusion of a gel extraction step in sequencing library prep 
(17, 37). 
The development of the funbut primer set built upon these two approaches by amplifying 
functionally verified yet diverse but gene sequences.  The funbut primer set amplifies a higher 
diversity of but genes than the primers described by Flint et al., and fewer non-but paralogues 
than the primers described by Vital et al.  However, as is the case with most primer sets, these 
will likely miss or under represent some important groups.  For example, although we detected 
some but sequences similar to those of Faecalibacterium, these appeared at a much lower 
abundance than would be expected from 16S rRNA gene sequence-based studies of the swine 
gut.  Importantly, due to the increased specificity of the funbut primers compared to the Vital et 
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al. primers, no incorrectly sized PCR product has been observed when amplifying from complex 
fecal or mucosal samples, even at annealing temperatures as low as 45 C.  This allows for the 
omission of the gel extraction step when preparing sequencing libraries, and for the possibility of 
using these primers in SYBR-based qPCR assays. 
The active members of the butyrate-producing community differ from the abundant members 
The new but primers detected striking differences in community composition from the 
same starting material (proximal colon contents) depending on whether DNA or RNA was used 
as the template.   Sequences detected in DNA-derived libraries are not necessarily being 
transcribed and translated into proteins, and may be representative of microbes simply passing 
through the intestinal tract, or those utilizing an alternative metabolism not involving butyrate 
production.  At best, DNA-based but libraries represent the functional potential in the ecosystem.  
In contrast, sequences detected in RNA-based libraries represent microbes that are actively 
transcribing but genes.  These active microbes represent a subset of the total but-containing 
community; however, we detected a greater diversity of but genes in the RNA-based libraries 
than in the DNA-based libraries.  Other studies have identified similar differences between the 
metagenome and metatranscriptome, such as the observation that functional genes for 
methanogenesis in the human gut were far more abundant in the metatranscriptome compared to 
the metagenome (50).  This reinforces the idea that the gut ecosystem contains microbes that 
may be in low abundance but are highly active, and that DNA-based studies may overlook their 
importance.  When profiling the butyrate-producing community, RNA may be a more 
appropriate source molecule rather than DNA.   
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The phylogenetic relatedness of But protein sequences informs potential function   
Within the currently defined But protein family there are genes encoding functional But 
enzymes and very similar paralogues.  Both of these groups are more similar to each other than 
to the next most similar gene family, the 4-hydroxybutyrate transferases.  One large clade 
harbored the vast majority of functionally confirmed but genes as well as the majority of all but-
related OTUs detected, supporting the use of phylogenetic analyses to predict function for this 
family of But proteins.  Outside of this clade, functionally confirmed and unconfirmed But 
enzymes were interspersed (Figures 7,8). However, this work does not rule out the possibility 
that paralogues also exist in the main functional clade as well.  Because But enzyme activity is 
advantageous in colonic ecosystems, it is possible that enzymes specializing in this function have 
evolved multiple times from different ancestor proteins.  Work by Eeckhaut et al. identified But 
enzyme activity from bacteria that lacked genes similar to but genes or their paralogues (19).  
They proposed that genes most similar to propionyl-CoA transferases were responsible for But 
enzyme activity in these organisms.  Additional discovery and analysis of butyrate-producing 
organisms is required to delineate the full functional sequence diversity of deeply branching But 
protein sequences and identify other protein families capable of But enzyme activity.  
Further emphasizing the need to more fully characterize this family, and in agreement 
with previous gene-targeted studies, (17, 37) we detected many OTUs with low identity to both 
confirmed sequences and cultured organisms.  This work reveals many gaps in our knowledge of 
the but gene family.  Due to the importance of this bacterial function in nearly all colonic 
ecosystems, better characterization of this community is necessary. It follows that culturing 
novel butyrate-producers and identifying their functional genes remains and important step to 
improve but datasets.   
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Potential Identities of some but gene paralogues 
Many similar fatty acid CoA-transferases are easily confused for but genes.  The 4-
hydroxybutyryl-CoA: acetate CoA-transferases (4-hbt) are known to be similar; however,  
several researchers have been investigating genes that are more similar to but genes than 4-hbt 
genes and are required for full pathogenicity in Yersinia pestis and Salmonella (51).  These genes 
have been proposed to be itaconate –CoA transferases. They transfer a CoA group from 
succinyl-CoA onto itaconate, thus activating it and enabling its degradation into acetyl-CoA and 
pyruvate.  Indeed, many entries in the Fungene database for but-like genes are from Salmonella 
and Yersinia genomes.  These genes cluster more closely with functionally confirmed but genes 
than to the 4-hbt genes.  It is likely that many other genes that closely resemble but genes act to 
move CoA moieties among various fatty acids. 
Analyses of butyryl-CoA transferases in the animal intestinal ecosystem enable the study 
of a functional aspect of the gut microbiota and how it relates to health and disease.  This 
research provides a tool to investigate functional butyrate transferases in the swine gut 
microbiota, and could also be applied to other animals, other environmental samples, or could be 
used to generate but amplicon data sets from metagenomic samples.  This advances the analyses 
of the host-associated butyrate-producing community for enhancing swine health and improving 
food safety.  
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Abstract 
A Gram-positive, non-motile, butyrate-producing coccus was cultured from the distal ileum of 
swine.  This organism was isolated on rumen fluid medium, consumes acetate, and produces 
butyrate as a major end product.   A phylogenetic analysis based on full-length 16S rRNA gene 
sequences as well as whole-genome phylogenies suggests that this isolate is most closely related 
to species in the genus Butyricicoccus, with B. pullicaecorum being the closest named relative 
(93.5% 16S identity).  The draft genome is available through GenBank under accession number 
NHOC00000000.  The G+C content of this isolate is 54 mol%, and the major cellular fatty acids 
are C16:0, C18:0, C14:0, C15:0-anteiso, and C15:0-iso.  These data indicate that this isolate represents a 
novel species within the genus Butyricicoccus, for which we propose the name Butyricicoccus 
porcorum sp. nov.  The type strain of Butyricicoccus porcorum is BB10T (ATCC XXXXXT, 
DSM 104997T). 
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Introduction 
The family Ruminococcaceae harbors many important intestinal commensal organisms, 
though study of this family has lagged behind other intestinal commensal families such as the 
Lachnospiraceae (based on the number of public genome assemblies, 188 vs. 427, respectively).  
Members of the Ruminococcaceae family participate in a diverse array of functions, and many of 
its members are butyrate producers.  Butyrate is a compound excreted by bacteria as they 
ferment dietary fiber in the large intestine and is necessary for maintaining intestinal homeostasis 
and resistance to certain enteric pathogens (1-10).  As a result, having cultured representatives of 
butyrate-producing bacteria is important to study their interactions with the host, diet, and 
pathogens.  The genus Butyricicoccus is within the family Ruminococcaceae, and several 
members of this genus have been isolated (11-19), yet most remain uncharacterized.  One study 
has shown that members of this genus are mucosa-associated and are reduced in patients with 
ulcerative colitis (20).  Members of this phylogenetic group, such as B. pullicaecorum, can have 
beneficial impacts on the host, including a reduction in the severity of 2,4,6-trinitrobenzene 
sulfonic acid (TNBS) induced colitis (21) and more recently some beneficial outcomes for 
poultry in a model of necrotic enteritis (22).  Several Butyricicocci have been isolated from the 
swine intestinal tract, yet they are all unique isolates based on 16S rRNA sequence identity and 
phylogenetic placement.  Here we describe strain BB10, an isolate from the swine intestinal 
tract, and suggest that it represents a novel species of the genus Butyricicoccus. We propose the 
name Butyricicoccus porcorum sp. nov. for this species.    
The taxonomy of the clade containing the Butyricicocci is currently conflicted. For 
example, two research groups have each suggested a different taxonomic fate for the species 
Eubacterium desmolans.  Takada et al. have suggested that E. desmolans, along with their novel 
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isolate, B. faecalihominis KS-2,  be classified into the existing Butyricicoccus genus (13). In 
contrast, Ahn et al. have suggested that E. desmolans, along with their isolate A. 
butyriciproducens SR79,  be classified into the proposed genus Agathobaculum (12).   These two 
strains (B. faecalihominis KS-2 and A. butyriciproducens SR79) appear to be members of the 
same species as their 16S genes are 99% identical; however, neither genome sequence is publicly 
available, impeding additional comparisons.  This inconsistency in strain classification, in 
addition to the lack of characterization of strains from this phylogenetic neighborhood, show that 
a comprehensive comparison of all Butyricicoccus-related strains is needed to clarify the 
taxonomic boundaries of this genus. 
Isolation 
Strain BB10 was isolated from a 3-month-old pig fed a standard corn-based diet without 
recent exposure to antibiotics.  All bacterial manipulations were performed in a Coy anaerobic 
chamber (86% N2, 10% CO2, 4% H2).  At necropsy, mucosal scrapings were collected, 
homogenized in sterile anaerobic phosphate buffered saline, and serially diluted.  Dilutions of the 
homogenates were plated on rumen-fluid agar medium (RTY; supplement).  Plates were 
incubated anaerobically at 39°C for 2 days, then colonies were picked and re-streaked for purity.  
Isolates with unique morphologies were subjected to colony PCR and 16S rRNA gene 
sequencing with the primers 8F and 1492R. Analysis of the sequences using the Ribosomal 
Database Project’s online tools (23) revealed strain BB10 as a novel bacterial species based on 
sequence identity to known species (~93% identity to B. pullicaecorum). 
Growth characteristics 
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Strain BB10 grew well in RTY medium (Supplement) at pH 6.0.  A defined medium was 
designed to test utilization of distinct carbohydrates and amino acids, and all subsequent 
characterizations were carried out in this defined medium either with or without acetate (BB10 
characteriation media, supplement).  Optical densities at 600nm were measured using a 
BioReaderC plate reader in an anaerobic chamber. We next measured short chain fatty acid 
(SCFA) production by GC analysis under various growth conditions as described (24). BB10 
was unable to use complex carbohydrates and only showed robust growth (OD600 > 0.7) on 
mono- or di-saccharides.  Butyrate, CO2, and H2 were produced and acetate was consumed when 
grown on glucose, fructose, galactose, sucrose, maltose, or lactose. Moderate growth (OD600 > 
0.5) was observed on myo-inositol.   Weak growth (OD600 < 0.4) was observed when grown on 
raffinose. No growth (OD600 < 0.1) was detected when grown on trehalose, mannitol, mannose, 
glycerol, melezitose, sorbitol, rhamnose, n-acetylglucosamine, n-acetylgalactosamine, arabinose, 
cellobiose, fucose, xylose, inulin, pectin, potato starch, or mucin.  In addition, strain BB10 was 
unable to use any free amino acids as a carbon source. These results suggest that BB10 requires 
simple carbohydrates and lacks the ability to metabolize complex substrates in isolation.  
Morphology 
 Phase-contrast microscopy revealed that cells of BB10 cultured in RTY medium were 
non-motile. Cells of BB10 were prepared for transmission electron microscopy from stationary 
phase cultures (48 hours), and were negatively stained with osmium and then visualized under a 
Tecnai 12 G2 Biotwin microscope for measurements. Cells of BB10 were cocci and were 
approximately 1.5µm in diameter, and they occurred singly, in pairs, and in tetrads during the 
stationary phase (Figure S1A).  During the early growth phase the cells appeared as irregular 
agglomerations of larger spherical protrusions (Figure S1B).  Cells showed an affinity to clump 
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together as if they were bound by an extracellular matrix.  In liquid culture, cells of BB10 
clumped together in a mucoid mat (Figure S2).  TEM micrographs revealed a capsule 
surrounding the cell wall (Figure 1).  
 
Genomic analysis and comparison with other Butyricicocci 
 All available genomes for members of the putative Butyricicoccus clade of the 
Ruminococcaceae family were uploaded to RAST (25) for annotation, metabolic prediction, and 
comparison with BB10 (Genbank accession NHOC00000000).   BB10 contained many genes 
that putatively encode exopolysaccharide biosynthesis and modification of the capsule with sialic 
acid.  This supports our observation of an apparent extracellular capsule (Figure 1) and of 
mucoid aggregates in liquid culture (Figure S2).  The ability to secrete exopolysaccharides has 
Figure 1: A TEM micrograph of BB10 showing cells surrounded by a polysaccharide capsule 
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important implications for host health in another well-known member of the Ruminococcaceae, 
Faecalibacterium prauznitzii.  Rossi et. al. demonstrated that a strain of F. prauznitzii secreted 
an exopolysaccharide matrix and  attenuated dextran sodium sulphate (DSS) induced colitis 
better than one that did not produce exopolysaccharides (26).  All of the other members of the 
putative Butyricicoccus clade lacked the ‘exopolysaccharide biosynthesis SEED subsystem’ as 
determined by RAST.   
Several genomic predictions were shared by several putative Butyricicocci.  All members 
were predicted to be butyrate producers.  In accordance with our previous genomic investigation 
(27), the complete butyrate synthesis pathway was present in BB10 and was predicted to 
terminate with the but gene.  The genome also revealed the absence of the ability to degrade 
complex polysaccharides, which is in agreement with the culture-based assay results.  Indeed, 
most of the cultured and genome-sequenced representatives of this clade lack the ability to 
degrade complex substrates.  For example, Takada et al. report that strain B. faecihominis was 
isolated from a mucin enrichment culture, yet this bacterium lacks the genes required to degrade 
the complex mucin molecule on its own.  The authors suggest that B. faecihominis grows on the 
degradation products from other mucin-degrading bacteria.   Additional examples are the 
uncultured putative Butyricicoccus members that do not encode glycoside hydrolases and 
relatively few carbohydrate transporters; these organisms were described as “Clostridial 
scavengers” (28).   In contrast to BB10, E. desmolans, and B. faecihominis, some putative 
Butyricicocci, including both A. butyriciproducens and B. pullicaecorum, were reported to 
hydrolyze complex carbohydrates (starch)(11, 12). 
Not all genomic-based predictions were supported by our phenotypic observations.  
Many genes in BB10 were annotated as encoding spore formation, but sporulation was not 
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observed in the growth conditions tested. Similarly, the genomes of all members of this clade 
contained many genes annotated as encoding spore formation, yet no described isolates of this 
clade have been observed to form spores.  Additionally, the genome annotation of BB10 suggests 
genes encoding mannose and mannitol utilization; however, growth was not detected on these 
substrates.    
GC content was calculated from genome sequences using a BioPython script (29), or 
taken from previous publications when available (Table 1).  The average GC content of this 
clade is 54.7 mol%, the minimum is 52.9 mol% (A. butyriciproducens), the maximum is 56.9 
mol% (Butyriciccoci. spp. 2789STDY5834927), with a standard deviation of 1.1 mol% 
considering all currently available data.     
Table 1:  The various strains identified to belong to clade containing described Butyricicoccus 
species 
Strain Host %16S ID to BB10 
GC 
content reference 
B. porcorum BB10 Pig 100 54 - 
B. pullicaecorum 25-3 Chicken 93 54.5 14 
B. 2789STDY5834927 Human 92 56.9 25 
B. sp. N54.MGS-46 Human 92 55 2 
Clostridiales bacterium DJF-B152 Pig 93 - 19 
butyrate producing bacterium A2-207 Human 92 - 21 
Agathobaculum butyriciproducens SR79 Human 93 52.9 15 
B. sp. K4410.MGS-46 Human 92 55.6 2 
bacterium NLAE-zl-C313 Cow 94 - 18 
Clostridiales bacterium 7-4c chicken 91 - 22 
B. faecihominis KS-2 human 92 55.6 16 
bacterium NLAE-zl-C312 cow 93 - 18 
bacterium NLAE-zl-H60 Human 93 - - 
bacterium NLAE-zl-H55 Human 93 - - 
Eubacterium Desmolans ATCC 43058 Cat 91 54.3 20 
bacterium NLAE-zl-H41 Human 93 - - 
bacterium NLAE-zl-C141 Cow 92 - 18 
Clostridiales bacterium DJF-CP67 Pig 92 - 19 
B. 2789STDY5834926 Human 94 53.7 25 
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Phylogenetic Analysis 
 The genetic relatedness of strain BB10 to known bacterial species was evaluated by 
phylogenetic analysis.  Full-length 16S rRNA gene sequences from defined members of the 
family Ruminococcaceae were downloaded from Genbank (12, 13, 30), and those classified as 
Butyricicoccus were downloaded from RDP rather than NCBI because the NCBI taxonomy 
grouped several putative Butyricicocci in the genus Eubacterium (23).  Publicly available 
genome sequences for organisms closely related to members of the Butyricicoccus genus were 
downloaded, including several uncultured or unclassified putative Butyricicoccus members (28, 
31).  When appropriate, the 16S rRNA gene sequences were extracted with RNAmmer (32). All 
16S rRNA gene sequences were aligned to the SILVA reference alignment (33) using mothur 
(34), and then a maximum-likelihood tree was generated with RAxML including bootstrap 
support values (Figure 2) (35).  Code for this analysis is available at 
https://github.com/Jtrachsel/BB10-IJSEM. BB10 clustered with members of the genus 
Butyricicoccus and this clade was separate from the other clades within the Ruminococcaceae 
family.  This analysis suggested that strain BB10’s closest cultured relative is an unnamed 
bacterial species isolated from the intestinal tract of a pig in Denmark, Clostridales bacterium 
DJF-B152 (16).   A genome-based phylogenetic analysis on the previously mentioned publicly 
available genomes was conducted in PhyloPhlan (36) to confirm the 16S rRNA gene sequence-
based phylogeny.  The genome-based phylogeny was congruent with the 16S rRNA gene 
sequence phylogeny, supporting the assignment of strain BB10 to the Butyricicoccus genus 
within the Ruminococcaceae family (Figure S3). 
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Figure 2: A maximum likelihood tree of full-length 16S rRNA gene sequences from closely related 
Ruminococcaceae family members.  Blautia coccoides is provided as an outgroup.  Bootstrap values 
are shown at the nodes and represent 1000 samplings. 
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Host range 
All cultured putative members of this clade have been isolated from the intestinal tracts 
of animals (Table 1).  A study by Ziemer et. al. isolated several putative members of this genus 
from enrichment cultures of bovine and human feces on complex polysaccharides (15).   Eekhaut 
et. al. have isolated members of this clade from the intestinal tracts of chickens (19, 30), and 
several studies have isolated members of this clade from human feces (12, 13, 18, 31).  Full-
length 16S rRNA gene sequences nearly identical (99.7%) to that of BB10 have been detected in 
the feces of pigs in Japan (37) and Canada (38), but have not been reported in other animals.  
Finally, in our recent functional gene-based study on the butyrate-producing community in the 
swine proximal colon, we identified many partial butyrate transferase-encoding (but) gene 
sequences that were 100% identical to BB10’s but gene, suggesting the presence of bacteria very 
similar to BB10 in the colons of these pigs (27).  Taken together, these data suggest that BB10 is 
a characteristic member of the intestinal microbiota of swine, and that members of this 
phylogenetic clade are typical members of the intestinal microbiota of many animal species. 
Proposed ecological niche of BB10 
The biochemical and genomic description of BB10 provides some initial insight into its 
ecological niche in the gut.  Because of the lack of enzymatic machinery or genes to utilize 
complex substrates in isolation, it is likely that BB10 fits the description of ‘Clostridial 
scavenger’ as described in (28).   Additionally, it was isolated from the mucosa, and it can 
metabolize host-derived sugars such as galactose, and so it is likely a butyrate-producing 
mucosae-associated scavenger.  Other members of the Butyricicoccus genus have been found to 
be strongly associated with the mucosa as well (39). Robust occupation of this niche can be 
beneficial for host health and colonization resistance in a number of ways.  First, butyrate 
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production is well known to improve mucosa health and enhance resistance to colonization by 
pathogens (5).  Secondly, a robust population of scavengers at the mucosa can quickly utilize 
available simple substrates, thereby depriving pathogenic organisms of access to their preferred 
food sources (40). 
Probiotic potential 
 BB10 has many features that suggest it may be an attractive probiotic candidate; 
however, its use as a probiotic faces serious obstacles.  Butyrate-producing bacteria are 
increasingly being considered for probiotic administration and some advances have been made, 
even within the genus Butyricicoccus (30, 41-44).  However, like BB10, many butyrate-
producing bacteria are strict anaerobes, and this poses some special problems for their use as 
conventional probiotics.  Any exposure of BB10 to oxygen in our experiments quickly resulted 
in cell death, making conventional probiotic administration techniques problematic.  
Additionally, even under anaerobic conditions, we observed significant autolysis and loss of 
viability after 5 days.  This loss of viability was observed in both liquid and agar-based culture 
conditions in a variety of media formulations.  Therefore, although BB10 likely has beneficial 
impacts on the host due to butyrate-production and its role as a potential mucosal scavenger, its 
applications as a probiotic are currently limited. 
 Future work may contribute to overcoming the challenges associated with developing 
BB10 as a probiotic.  Most of the obstacles for utility as a probiotic that we identified stem from 
BB10’s apparent fragility and inability to survive long-term outside of the GI tract.  However, 
because BB10 is a commonly occurring member in swine gut microbiota worldwide, it must 
harbor some mechanisms that aid its dispersion and transmission between hosts.  Sporulation is 
the most obvious mechanism that could achieve this (45), and indeed we detected many genes 
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thought to be important for sporulation in BB10’s genome.  Although we were not able to 
observe spore formation in our studies, it may be that we did not have the correct culture 
conditions to stimulate spore formation or germination.  Future investigations into this bacterium 
may yield data that allow its use as an effective probiotic organism. 
Description of Butyricicoccus porcorum sp. nov. 
Butyricicoccus porcorum (por.co’rum. L. n. porcus swine, pig; L. masc pl. n. porcorum of/from 
pigs). 
Cells are obligately anaerobic, non-motile, and coccus shaped.  Cells ferment simple mono- and 
disaccharides.  Products of fermentation are butyrate, H2 and CO2, dependent on a consumption 
of acetate.  Robust growth is obtained in rumen-fluid media or defined media supplemented with 
acetate.  Optimal growth occurs at 39°C and pH 6.0.  After 2 days of growth on agar, colonies 
are white to off white, ~2 mm in diameter, convex and smooth.  In liquid culture this strain 
aggregates into a mucoid mat.  The main cellular fatty acids are C16:0, C18:0, C14:0, C15:0-anteiso, 
and C15:0-iso.  This strain is a common inhabitant of the swine intestine. 
The type strain, BB10T (ATCC XXXXX, DSM 104997T), was isolated from the distal ileum of a 
pig in Ames, Iowa, USA.  The DNA G+C content of the type strain is 55 mol%. 
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Supplemental Material 
 
 
 
Figure S1: Phase contrast light micrographs of wet mounted BB10 cells at 640x magnification A: 
After 48 hours of growth on solid agar media. B: After 24 hours of growth on solid agar media 
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Figure S2: BB10 morphology after 48 hours of growth in A: liquid BB10 general growth medium, B: 
BB10 general growth agar medium 
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Figure S3: A maximum likelihood tree with bootstrap support values; generated from the 
concatenated protein alignment output by Phylophlan.  Only organisms with publicly available 
genome assemblies are included here.  Blautia obeum ATCC 29174 is provided as an outgroup.   
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Figure S4: An SEM of BB10 cells after 36 hours of growth 
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BB10 general growth media (per liter): 
Tryptone peptone 5g 
Yeast extract 5g 
Resazurin (0.1% w/vol) 1mL  
Salt solution 1A 40 mL 
Salt solution 2B 40 mL 
Hemin solutionC  1 mL 
Vitamin K working stockD 1 mL 
Cysteine HCl 0.5 g 
Glucose 2.5 g 
Galactose 2.5 g 
Lactose 2.5 g 
Maltose 2.5 g 
Sodium Acetate 4.5g 
dH2O up to 1 L 
 
BB10 Characterization media (per liter): 
Tryptone peptone 5g 
Yeast extract 2.5g 
Resazurin (0.1% w/vol) 1mL  
Salt solution 1A 40 mL 
Salt solution 2B 40 mL 
Hemin solutionC  1 mL 
Vitamin K working stockD 1 mL 
Cysteine HCl 0.5 g 
Add carbohydrate of interest at 1% w/vol 
Sodium Acetate 4.5g 
dH2O up to 1 L 
 
RTY-rumen fluid (per liter): 
Tryptone peptone 5g 
Yeast extract 2.5g 
Resazurin (0.1% w/vol) 1mL  
Salt solution 1A 40 mL 
Salt solution 2B 40 mL 
Hemin solutionC  1 mL 
Vitamin K working stockD 1 mL 
Cysteine HCl 0.5 g 
Glucose  10g 
Sodium Acetate 4.5g 
Clarified Rumen fluid 300 mL 
dH2O up to 1 L 
 
ASalt solution 1 (per liter): 
K2HPO4 6 g 
BSalt solution 2 (per liter): 
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KH2PO4 6 g 
(NH4)2SO4 12 g 
NaCl 12 g 
MgSO4 · 7H2O 1.2 g 
CaCl · 6H2O 1.2 g 
CHemin solution: 
0.5g Hemin into 10 mL 1M NaOH. Bring up to 100 mL in dH2O. Store at 4 C. 
DVitamin K solution: 
Stock: 0.02 mL vitamin K into 2 mL 95% ethanol. Store in dark at 4 C. 
Working stock: add 1 mL stock to 9 mL d H2O. Use within 3 days. 
Cultivation 
Cells of BB10 are strictly anaerobic, any exposure to oxygen results in non-viability.  We 
routinely grew BB10 in media using resazurin as a redox indicator. Any media that was slightly 
pink was unable to support growth.  All manipulations were performed in a Coy anaerobic 
chamber with an atmosphere of 86% N2, 10% CO2, 4% H2.   For long term storage of BB10 
cells, glycerol freezer stocks were found to be most effective.  Briefly, we inoculated liquid 
BB10 general growth medium and allow cells to grow for 24-48 hours.  Ensuring the cells were 
evenly distributed throughout the culture, we added 500uL cells to 1.8mL screw-top cryovials, 
then added 500uL BB10 general growth media containing 20% glycerol.  We sealed the 
cryovials in the anaerobic chamber, then froze at -80 C. 
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Introduction 
Weaning is a stressful time in the life of a piglet.  In rapid succession, weaned piglets 
experience a diet change, transport stress, exposure to previously unencountered pathogens, the 
stress of social integration, and the decline of maternal-derived antibody protections. All of these 
factors leave the weaned piglet susceptible to infections and complications such as post-weaning 
diarrhea (1).  To combat these weaning-associated diseases, antibiotics are routinely given to 
nursery-aged pigs.  In its 2012 National Animal Health and Monitoring System (NAHMS) 
report, the USDA reported that almost 90% of nursery sites and almost 98% of wean-to-finish 
sites administered in-feed antibiotics that year (2).  These statistics underscore the need for 
alternative treatments aimed at supporting the piglet through the post-weaning period.  Dietary 
prebiotics, such as resistant starches, provide an attractive alternative to antibiotics in this regard 
(1, 3).  
  Resistant starches are dietary compounds that escape host digestion and improve gut 
health by delivering microbial-accessible carbohydrates (MACs) to the large intestine.  The 
microbes that consume resistant starches are normal members of the microbiota and are 
associated with intestinal health (4-8).  Recently, it has been shown that without access to diet-
derived carbohydrates, commensal bacteria will harvest host-derived sugars from the mucus 
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layer, degrading and compromising its barrier function (9). However, if ample dietary MACs are 
present, intestinal microbes will consume them and release beneficial metabolites, such as short 
chain fatty acids (SCFAs) in the process.  Host tissues consume the vast majority of these 
SCFAs, and in part this fuels the effort to maintain intestinal homeostasis (10, 11).  For example, 
microbiota-derived SCFAs are known to fuel B-cells and enhance their IgA responses (12).  
While most SCFAs can be used by host tissues, butyrate has been shown to be of special 
importance for many aspects of gut health.   
Butyrate is a central metabolite for maintaining intestinal homeostasis.  It is the preferred 
fuel source for colonocytes which, while oxidizing butyrate, consume considerable amounts of 
oxygen.  This lowers the oxygen potential of the epithelia, reducing the amount of electron 
acceptors available for microbial respiration and favoring species that use a fermentative 
metabolism and preventing the overgrowth of facultative anaerobic bacteria, including 
opportunistic pathogens such as certain Salmonella and E. coli species.  Butyrate also aids in the 
maintenance of homeostasis by regulating the expressions of many genes in host tissues via 
histone deacetylase inhibitor activity.  Exposure to butyrate and other SCFAs has been shown to 
increase mucus and antimicrobial peptide secretion (13-16), and shift host immune responses to a 
more tolerogenic phenotype (17-20).  These changes help to limit inflammation and, in doing so, 
reduce the amount of immune-derived reactive oxygen species or other electron acceptors that 
can support microbial respiration, further limiting the niche for facultative anaerobes (21, 22). 
Resistant starches are a potential feed additive to improve gut health and reduce the need 
for antibiotic treatment for post-weaning disease susceptibility in pigs.   Some pig producers are 
currently feeding raw potato starch (RPS )to nursery-aged pigs and its use has shown some 
promising benefits (23).  However, the mechanisms by which resistant starch, and specifically 
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RPS, supports intestinal health in the weaned piglet are poorly defined.  Here we investigate how 
RPS intake can benefit interactions between the intestinal microbiota and the host.  The results 
reported here suggest that dietary resistant starches can help support beneficial host-microbe 
interactions in the piglet’s intestinal ecosystem, increasing resistance to disease by limiting the 
niche for mucosal pathogens. 
Methods 
Experimental design 
Ten pregnant, Large White crossbred sows were delivered to the National Animal 
Disease Center (NADC) 2 weeks prior to farrowing and were farrowed onsite.  At 14 days-of-
age, piglets were offered non-amended Phase 1 starter diet (Table S1) in small bowls placed into 
each farrowing pen. At 21 days-of-age, piglets were weaned, and separated into 2 treatment 
groups. Each group consisted of two pens of 7 piglets for a total of 14 piglets in each treatment 
group. The control group continued to receive non-amended Phase 1 Starter Diet. The treatment 
(RPS) group was fed Phase 1 Starter Diet amended with 5% raw potato starch (MSP Starch 
Products Inc., Carberry, Manitoba, Canada). At 33 days-of-age (12 days post-weaning), the 
control group was switched to Non-amended Phase 2 Diet and the RPS group piglets were 
switched to Phase 2 Diet amended with 5% raw potato starch (Table S1).  At 42 days-of-age (21 
days post-weaning), 7 piglets from each group (3 from one pen and 4 from a second pen) were 
humanely euthanized and various intestinal samples were collected. 
Flow Cytometry 
Cecal tissues were gently rinsed in PBS to remove digesta. A 2 g section was placed in 
complete (c) RPMI (RPMI 1640 [Life Technologies; Grand Island, NY] supplemented with 10% 
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fetal calf serum [FCS, Omega Scientific; Tarzana, CA], L-glutamine [Life Technologies], 25 
mM HEPES [Sigma; St. Louis, MO], and essential amino acids and antibiotics [Sigma]) and 
stored on ice until processing.  Protocol has been previously described in (Goodyear et al. 2014). 
All centrifugation steps were 450 x g for 8 min at 4°C. Tissue was added to 30 mL solution of 5 
mM dithiothreitol (DDT) (cat: 15508-013, Invitrogen) and 2% fetal calf serum (FCS) in 
calcium/magnesium-free Hank's balanced salt solution (HBSS), and incubated at 37°C and 
agitated at 200 rpm for 20 min. Tissue was transferred to 30 mL epithelial removal solution 
containing 5 mM EDTA and 2% FCS in HBSS, and incubated for 15 minutes on the shaker as 
above. This was repeated and the epithelial cells released during these 2 steps were collected by 
centrifugation. The remaining tissue was transferred into a wash solution containing 10 mM 
HEPES (Sigma) in HBSS and incubated for 10 min on the shaker as above. Tissue was 
transferred to a C-tube (Miltenyi Biotec) with 14 mL enzyme digestion media containing 1% 
HEPES in HBBS, with 0.2 U/mL Liberase TM Research Grade (Roche Life Sciences), and 30 
μg/mL DNase I (cat: D5025, Sigma Aldrich), minced with scissors, and processed on 
gentleMACS Octo Dissociator (Miltenyi Biotec) intestine setting for C-tubes before and after a 
45 min incubation on the shaker as above. Debris was removed by filtration through a gauze pad 
and enzymes were inactivated by addition of 7 mL cRPMI. Cells were run over a 40 μM filter to 
remove debris, collected by centrifugation, and resuspended in HBSS containing 200 mM L-
glutamine and 2% FCS. Epithelial cells released after incubation in EDTA solution were 
recovered via the same centrifugation and combined with cells from the lamina propria. 
Approximately 106 cells per animal were used for flow cytometric analysis.  
Cells were stained with Zombie Yellow Viability dye, followed by incubation with 
fluorescently-conjugated anti-porcine monoclonal antibodies purchased from BD Biosciences, 
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San Jose, CA (except as noted), Antibodies used included anti-porcine CD3 (clone BB23-8E6-
8C6, cat: 561477), CD4 (clone 74-12-4, cat: 559585), CD8α (clone 76-2-11, cat: 559584ID), 
CD25 (clone K231.3B2, Southern Biotech cat: 1070-19), and FOXP3 (clone FJK16s, cat: 48-
5773-82). A cocktail of all surface marker antibodies was added to each cell suspension, 
followed by fixation and permeabilization for intracellular staining with anti-Foxp3 antibody 
using Intracellular Nuclear Staining Kit according to manufacturer’s recommendations 
(Biolegend). Data was acquired on a BD LSRII machine and data was analyzed with FlowJo 
Software. Representative flow plot is available Figure S1. 
RNA extraction, cDNA synthesis, and RT-qPCR of cecal tissue 
Cecal mucosal scrapings were stored in RNAlater® (Life Technologies) at 4°C. RNA 
was extracted using the TriReagent (Life Technologies)-modified protocol of the PowerLyzer 
UltraClean Tissue & Cells RNA Isolation Kit (MoBio Laboratories, Inc.) following 
manufacturer’s instructions. Homogenization in TriReagent was carried out in a Thermo Savant 
FastPrep® FP120 Cell Disrupter (Qbiogene, Inc., Carlsbad, CA) with 2 cycles of 45 seconds at 
4.0 m/sec and a 30 second pause between cycles. An on-column DNA removal step was included 
(On-Spin Column DNase I Kit, Mo Bio Laboratories, Inc.).  Genomic DNA (gDNA) removal 
and cDNA synthesis (1 ug), were carried out with QuantiTect Reverse Transcription Kit 
(Qiagen, Valencia, CA). 
Recipes for qPCR reactions included 3 μL cDNA, 10 μL TaqMan® Universal Master 
Mix II (Applied Biosystems, Foster City, CA), with uracil N- glycosylase (UNG)  
(ThermoFisher), 1 μL Primer/Probe Mix (Life Technologies, Table 2), and 6 μL Nucleic Acid-
free water.  Cycling conditions were 40 cycles of 95°C for 15 sec and 60°C for 1 minute. The 
reference gene β-actin was used to normalize the relative expression of genes of interest 
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according to the 2-ΔΔCq method as described by (Schmittgen and Livak 2008). Genes are 
described in Table S2. 
Microbial community analysis 
Feces and cecal contents were collected fresh and stored at -80 C until processing.  
Additionally, cecal contents as well as mucosal scrapings from two 4 x 6 inch sections were 
preserved in 5 mL RNAlater® each until RNA extraction.  DNA and RNA was extracted using 
the PowerMag fecal DNA/RNA extraction kit (MoBio).  RNA samples were treated with DNase 
Max (MoBio) kit to remove gDNA and converted to cDNA using the High Capacity cDNA 
Synthesis Kit (Applied Biosystems).  Amplicons of the V4 region were generated and sequenced 
in accordance with the protocol outlined in Kozich et al. (24).  The PCR conditions were:  2 min 
at 95°C, 22 cycles of [20 sec at 95°C, 15 sec at 55°C, 5 min 72°C], 72°C for 10 min.  Libraries 
were normalized using the SequalPrep Normalization Plate Kit (LifeTechnologies) and 
quantified using Kapa SYBR Fast qPCR (Kapa Biosystems, Wilmington, MA).  Normalized 
pools were sequenced using version 2 (250x2) chemistry on the MiSeq instrument (Illumina). 
Amplicons of the but gene were generated and sequenced using the protocol described in (25).  
Briefly, but genes were amplified from purified DNA or cDNA using AccuPrime Taq and the 
funbuts primers. The ﬁrst-step PCR mixtures contained each primer at 500 nM and 100 ng of 
template and used an annealing temperature of 45°C for 35 cycles. The second PCR step was 
performed in accordance with the protocol using Kapa Hifi polymerase (Kapa Biosystems, 
Wilmington, MA) and the Nextera XT version 2 indices (Illumina, city, state). This library was 
sequenced on a MiSeq using a 2 x 300 V3 reagent kit (Illumina) to generate 300-bp paired-end 
reads. 
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Microbial Glycoside Hydrolase activities 
Glycoside hydrolase assays were carried out as in Desai et al. 2016 (9).  The following 
substrates were tested:  4-nitrophenol sulphate, N-acetyl beta-D-glucosamide, beta-D 
galactopyranoside, alpha-L fucopyranoside, beta-D glucopyranoside, beta-D xylopyranoside, 
alpha-D galactopyranoside, and alpha-D glucopyranoside.  Total proteins were extracted from 
200 mg of feces in 1 mL of assay buffer (50 mM Tris, 100 mM KCl, 10 mM MgCl2; TritonX; 
protease inhibitor; pH 7.2) in a 96 well plate (2 mL deepwell) with 0.1mm beads.  Proteins were 
extracted by bead beating using a Retsch mixing mill (Retsch, Newtown, PA) at 30 cycles/ 
second for one minute and then placed on ice for 1 minute, repeated 4 times.  Debris was pelleted 
by centrifugation at 4500 x g for 10 minutes at 4 C. Protein concentrations were determined by 
Pierce BCA assay (Thermoscientific, Rockford, IL) and the same assay buffer was used to 
normalize protein concentrations.  Each assay received 10 ug of protein with a final substrate 
concentration of 10mM and a final volume of 150 uL in 100 well Bioscreen C plates (Growth 
Curves USA, Piscataway, NJ).  Plates were incubated at 39 C and absorbance at 405nM was 
measured every 2 minutes using a Bioscreen C plate reader.  Rates are reported as mM/s*ug 
protein. 
IgA measurements 
Cecal contents (~250 mg) were lyophilized, resuspended in extraction buffer at 30 mg 
dry weight per mL (recipe here), and then vortexed on high for 10 minutes.   Debris was pelleted 
by centrifugation at 5000 x g and the supernatant was used as an input in the Pig IgA ELISA 
Quantitation kit (Bethyl Laboratoties, Montgomery, TX). Results are reported as ng IgA/mg dry 
contents. 
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Short-chain fatty acid (SCFA) measurements 
One gram of material (cecal contents or feces) was resuspended in 2 mL PBS and 
vortexed for 1 minute, then debris was pelleted by centrifugation at 5000 x g for 10 minutes.  
Supernatant (1 mL) was added to heptanoic acid internal standards.  Butylated fatty acid esters 
were generated as described in (26) and analyzed using an Agilent 7890 GC (Agilent, Santa 
Clara, CA). 
Data analysis  
All R scripts used in this analysis are available at https://github.com/Jtrachsel/RPS-2017.  
Unless otherwise stated Wilcoxon tests were used to test for statistical differences between 
groups.  Both the 16s rRNA gene sequence and but amplicon data were clustered into OTUs in 
mothur using the Miseq SOP (27).  16S rRNA gene sequences were aligned to the SILVA 
reference alignment, and but sequences were aligned to an alignment of but reference sequences 
downloaded from RDP’s fungene database (28). 
The R package vegan (29) was used to carry out ecological diversity analyses.  For all 
community data types (16S rRNA gene sequences, but amplicons, flow cytometry data) samples 
were each rarefied to a standard number of observations.  Community structure similarity 
analyses were performed by calculating Bray-Curtis similarities, and statistical testing was 
accomplished using vegan’s Adonis and betadisper functions.  Differential abundance was 
determined using the DeSeq2 package (30).   
Correlations for network analysis were calculated with CCREPE (31) for compositional 
data or the rcorr function from the hmsic R package (32). Network layout and visualization was 
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done using the geomnet R package (33). Only significant, positive correlations with a Spearman 
coefficient of at least 0.6 are shown.   
Results 
Microbial changes through the post-weaning period 
We first assessed changes in the microbiota over time after weaning regardless of RPS 
treatment.  Both of the treatment groups experienced similar changes relating to the maturation 
of their microbiota over the 3 weeks after weaning. The phyla Proteobacteria, Synergistetes, 
Fusobacteria, Euryarchaeota, and Verrucomicrobia decreased in abundance while Bacteroidetes 
and Firmicutes increased over time after weaning (Figure 1A). Additionally, the RPS-fed pigs 
had an increase in the phylum Actinobacteria, driven mainly by an increase in the amount of the 
genus Bifidobacteria.  Changes in major phyla were reflected in a large shift in the community 
structure of the fecal microbiota (Figure 1B). The size of this effect was greater than the 
treatment effects.   
The functional capacity for carbohydrate utilization was also examined over time because 
we hypothesized that due to the diet change at weaning the gut microbiota would have an 
immature ability to degrade the new dietary substrates.  Fecal microbial glycoside hydrolase 
activities shifted as the gut microbiota matured (Figure 1C).  Importantly, we observed higher 
microbial hydrolase activities toward host-derived substrates early.  In particular, enzymatic 
activity to alpha-L fucopyranoside peaked at day 12 post-weaning and decreased as the piglets 
aged,  suggesting that more microbes were sourcing their carbon consumption from host-derived 
compounds rather than dietary-derived ones early in the post-weaning period. This spike was 
attenuated in RPS pigs, although the inter-group difference was not significant.  In contrast, we 
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observed gradually increasing hydrolase activities on plant-derived substrates throughout the 21 
days post-weaning, aligning with an enrichment of members of the microbiota that can 
metabolize plant glycans.  Taken together, the results show that the microbiota of the newly 
weaned pig shifts from metabolizing host glycans to plant glycans, and this shift is gradual 
despite the instant shift in diet at weaning.   RPS intake did not significantly alter these 
trajectories, though it tended to increase a-D-glucosidase activity (the activity required to digest 
RPS), group differences were not significant. 
 
 
Figure 1: A: Changes in major phyla of the fecal microbiota from day 0 to day 21 post-weaning. B: 
A Bray-Curtis based NMDS ordination depicting fecal microbiota community similarities from day 0 
to day 21 post-weaning. Ellipses indicate the standard error of the group C: Glycoside hydrolase 
activities of the fecal microbiota from day 0 to day 21 post-weaning.   
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Microbial communities of the treatment groups diverged as they matured 
Although the two groups experienced similar weaning-related changes in their microbial 
communities, the fecal bacterial community structures of the two treatment groups gradually 
diverged, (Figure 2A, Table S3) and by day 21 the two treatment groups had significantly 
different fecal microbiota community structures.  Group differences in community profiles were 
seen in both the broader 16S rRNA gene sequence-based bacterial community as well as the but-
based community (one important portion of the butyrate-producing community).  The two 
treatment groups did not have significantly different community structures until Day 15, which 
corresponded to a decrease in the lactose in the diets, as is common practice in commercial 
operations.  The size of these effects were driven in part by community dispersion (Figure 2B), 
with the 16S rRNA gene sequence analysis of the communities of the RPS pigs exhibiting 
significantly less group variability compared to the control pigs at day 21, and both groups 
became less dispersed as they matured (Table S4).  
 
 
Figure 2: A: PERMANOVA pseudo F statistic over time for both the 16S- and but-based fecal 
microbial communities.  This is a measure of how different the control and RPS fecal communities 
are at each timepoint.  P-values are shown at each timepoint. B: Group dispersion over time 
(calculated by the bdisp function from the vegan package).  
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Twenty-one days after weaning, the structure of the microbiota was significantly different 
between the treatment groups, and these differences resulted in differing profiles of microbial 
metabolites.  We observed differences in microbial community structure among many tissues, 
and the 16S rRNA gene sequence-based communities tended to be more different than the 
butyrate-producing communities (Figure 3A,B and Table S3).  This result suggests that changes 
in bacterial membership are only partially reflected in bacterial functions, which is likely due to 
the functional redundancy among members within an ecosystem. The tissue-associated microbial 
communities exhibited the same dispersion trend as the fecal communities, with the RPS 
communities exhibiting less group dispersion (Table S3).   
 
Short-chain fatty acid (SCFA) production in the cecum and feces was also evaluated to 
investigate whether the changes in bacterial membership and genetic potential had an impact on 
function. Aligning with the changes in microbial communities, the two groups had differing 
Figure 3: A: NMDS ordinations of 16S rRNA-based Bray-Curtis distances, points indicate group 
centroids and elipses are standard error. B: NMDS ordinations of but based Bray-Curtis distances, 
points indicate group centroids and elipses are standard error. C: SCFA concentrations from cecal 
contents and feces at day 21 post-weaning 
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SCFA profiles (Fig 3C).  Pigs fed RPS had higher levels of butyrate in both the cecum and feces 
(p=0.053 & p=0.048), lower levels of propionate in the cecum (p=0.053), higher levels of the 
metabolic intermediates lactate and succinate in the cecum (p=0.09 & p=0.01), and lower levels 
of lactate in the feces (p=0.02).  Total SCFA concentrations were not different between the 
treatment groups in the cecum but we observed significantly increased total fecal SCFAs in the 
RPS group (p=0.03).  These results show RPS induced changes in the bacterial communities of 
many tissues and that these changes affected SCFA production.   
Differentially abundant features between the treatment groups at Day 21 
At day 21 post-weaning, many bacterial genera were differentially abundant between the 
two groups (Figure 4) in several intestinal tissues (ileum, cecum, colon, and feces).  Several 
genera were consistently associated with each treatment group in all tissues tested.  Pigs fed RPS 
had significantly increased levels of Terrisporobacter, Sarcina, and Clostridium sensu stricto 1 
in all tissues. Pigs on the control diet had a significant enrichment of Mucispirillum in all tissues 
as well as sporadic enrichment of many Proteobacteria genera such as Helicobacter, 
Succinivibrio and Campylobacter.  One 16S rRNA gene sequence OTU is responsible for the 
differential abundance of Clostriduim sensu stricto 1 between the two groups, which is 
noteworthy because it suggests that one bacterium, not an entire genus, is sufficiently abundant 
to be differentially detected with the dietary treatment.  OTU00087 was strongly enriched in all 
tissues and at all timepoints in pigs fed RPS, and was virtually absent from control pigs (Figure 
5).  Sequences from this OTU most closely match Clostridium chartatabidum; organisms similar 
to this bacterial species are shown to tightly bind starch granules(34). 
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Figure 4: Differentially abundant genera (16S) as determined by DeSeq2. 
Figure 5: Abundance of OTU87 over time (A), and in various tissues (B)  
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Similar to the 16S rRNA gene sequence data, many but gene-based OTUs were 
differentially represented between the two groups (Figure 6).  RPS intake was consistently 
associated with a greater abundance of OTUs most closely matching Anaerostipes hadrus as well 
as an OTU that most closely matched an organism only detected in metagenomes from human 
feces (but OTU67). Additionally, several OTUs most closely matching Eubacterium rectale 
were enriched in feces.  Control animals had significant enrichments of OTUs most closely 
matching Pseudobutyvibrio and Helicobacter in several tissues.  These results suggest that 
certain butyrate-producing bacteria benefited from the dietary inclusion of RPS and were 
responsible for increased butyrate production in these animals. 
 
Figure 6: Differentially abundant but OTUs as determined by DeSeq2 across various tissues. 
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Bacterial food webs in the fecal microbiota 
To investigate microbial food webs responsible for the increased SCFA production in the 
RPS animals, we constructed a correlation network using but and 16S rRNA gene OTUs (Figure 
7). Nodes enriched in the RPS treatment group clustered into one primary subnetwork, whereas 
nodes enriched in the control group clustered into several smaller subnetworks.  The network 
was filtered to only include OTUs that were differentially abundant between the two groups, and 
so the primary subnetwork enriched in RPS-fed pigs represents bacterial OTUs that are involved 
in the fermentation of RPS to SCFAs.  Bacterial species found to be associated with the RPS-fed 
swine gut bacterial network are known to be involved in the fermentation of dietary starches, 
such as Eubacterium rectale, Mitsuokella spp., Prevotella spp., and Bifidobacterium spp.  These 
organisms degrade RPS into small polysaccharides or other metabolic inputs such as lactate, 
which are then an available carbon source for other bacteria.  Lactate-consuming and butyrate-
producing bacteria were also enriched in the RPS-fed 16S rRNA gene sequence and but gene 
OTUs network, including Megasphaera elsdenii. These results show that dietary RPS 
supplementation enriches for a bacterial food web that is optimized for degrading dietary fiber 
and producing SCFAs.  
Many butyrate-producing bacteria in gut ecosystems rely on other microbes to convert 
complex carbohydrate substrates into forms that they can use.  The correlation network between 
but gene and 16S rRNA gene sequence OTUs illustrates some of these partnerships.  Members of 
the genus Prevotella are known for their ability to breakdown polysaccharides and are highly 
abundant in swine (35), and we see several 16S rRNA gene sequence OTUs from the Prevotella 
7 group of this genus forming central nodes in the correlation network.  This highlights their 
importance in the early stages of dietary fiber and RPS breakdown, releasing of simple mono- 
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and oligosaccharides that feed other bacterial species.  Additionally, Bifidobacterium and 
Mitsuokella OTUs are central nodes in this network as well.  These lactate-producing bacteria 
have been shown to be important in the breakdown of dietary starches and to enhance butyrate 
production via cross-feeding with butyrate-producers (36).  These 16S rRNA-based OTUs 
correlate with but-based OTUs corresponding to well-known butyrate producers such as 
Megasphaera elsdenii, Eubacterium rectale, E. cellulosolvens, and Faecalibacterium 
demonstrating the importance of crossfeeding in butyrate production.    
 
Figure 7: A network depicting correlations between 16S and but OTUs in the fecal microbiota.  
Colors around the nodes indicate which treatment group that particular feature was enriched in as 
determined by DeSeq2.  The network was filtered using the following conditions: 1) Pvalue < 0.05, 
2) Spearman correlation coefficient > 0.6, 3) Nodes in a 16S-16S or but-but connection must be 
differentially abundant between treatment groups, 4) At least 1 node in a 16S-but connection must be 
differentially abundant between treatment groups.  
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Differential host response with dietary RPS  
In addition to the many changes in the bacterial communities and metabolites between 
the two treatment groups, we also observed simultaneous differences in the host immune 
response.  We used a panel of antibodies against CD3, CD4, CD8, CD25, and FoxP3 cellular 
markers in a flow cytometric assay to identify 16 distinct T-cell populations isolated from the 
cecal lamina propria, mesenteric lymph nodes, and peripheral blood.  The quantity of each cell 
type was reported as a percent of the total CD3+ cells, which is the general T-cell marker, 
generating a community data matrix which was used for ecological community analyses.   No 
significant differences were observed in T-cell community structures from the mesenteric lymph 
nodes or from peripheral blood; however, we observed a significant difference in the T-cell 
communities residing in the cecal tissues (Figure 8A) (PERMANOVA p=0.001, F=12.06). 
Additionally, the evenness of the cecal T-cell community in control animals was significantly 
reduced (Figure 8B, p = 0.02).  Several populations of T-cells were differentially abundant 
between the two groups (Figure 8C), showing that an expansion of CD8+ cell types and a 
reduction in FoxP3+ cell types in control animals was responsible for the differences in 
community structure and evenness between the two groups.  An additional flow panel was run to 
determine if significant numbers of gamma delta T cells existed in the CD8a+ population.  This 
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analysis revealed that only ~1% of CD8a+ cells also were positive for the gamma delta TCR in 
the cecal mucosa (data not shown).   
 
Figure 8: A) A Bray-Curtis based NMDS ordination of T-cell populations in various tissues, B) The 
evenness of the T-cell communities in various tissues, C) boxplots of significantly differentially 
abundant T-cell populations from the cecal T-cell community. 
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In addition to differences in the 
cecal T-cell communities, several other 
differences in the host immune response 
in the cecum were detected.  The 
expression of host genes involved with 
mucus production, barrier enhancement, 
and inflammation was queried. 
Significantly greater expression of 
MUC2 and IL-6 was observed, as well 
as a strong trend towards increased 
expression of DEF1B, in RPS fed animals compared to the controls (Figure 9A). MUC2 is the 
primary component of the mucus layer, IL-6 is an important signaling cytokine, and DEF1B is a 
host-produced antimicrobial peptide.  All three of these features are important for the barrier 
function of the mucosa.  In addition, luminal contents were assayed for IgA concentration 
because IgA is another important host-produced feature that enhances the barrier function of the 
mucus layer.  The results showed a trend towards increased luminal IgA in the RPS fed pigs 
(Figure 9B), increased secretion of IgA and a more robust mucus barrier. 
Microbial members and activities correlate with host responses  
To investigate correlations between bacterial membership, bacterial function, and host 
immune responses in the cecum, we constructed a correlation network using the data on cecal 
immune cell communities (both CD3+ and CD3- cell types were used in this analysis), cecal 16S 
rRNA gene sequence diversity, cecal SCFA concentrations, cecal host gene expression, and 
luminal IgA concentrations (Figure 10).  The results showed one discrete subnetwork associated 
Figure 9: A) mRNA expression of differentially 
expressed genes from the cecal mucosa. B) Amount of 
IgA in cecal contents 
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with each treatment group.  The subnetwork associated with pigs that were fed RPS showed 
clusters connecting markers of immune tolerance, mucosal barrier function, and anaerobic 
microbial fermentation.  Classical T-regulatory (CD3+/CD4+/CD8-/CD25+/FoxP3+) cells 
formed a central node in this subnetwork along with several other FoxP3+ cell-types.  The 
SCFAs butyrate, caproate, and valerate correlated with these regulatory immune cells.  Bacterial 
OTUs in this subnetwork belonged to groups known for anaerobic fermentation, and several 
OTUs correspond to known butyrate-producing groups such as the genus Megasphaera and the 
family Ruminococcaceae. In addition, this subnetwork contained nodes associated with 
promoting the mucosal barrier: MUC2, DEF1B, and IL-6 expression, and high luminal IgA 
concentrations.   
The subnetwork that associated with the control pigs showed markedly different clusters 
defined by immune activation, cytotoxic immune cells, and bacterial respiration.  Not all of the 
features of this subnetwork were significantly enriched in the control pigs.  Only CD3+/CD4-
/CD8+/CD25+/FoxP3-, CD3+/CD4-/CD8+/CD25-/FoxP3- cells, propionate, Succinivibrio, and 
Mucispirillum met this criteria.   The core of this subnetwork was composed of highly 
interconnected CD25+ immune cell types and a Campylobacter OTU, suggesting immune 
activation and or perhaps an ongoing immune response.   Many of the OTUs in this subnetwork 
belong to the Proteobacteria phylum, members of which are known to use respiratory 
metabolisms (37, 38).  Taken together, these results suggest that dietary RPS promotes bacterial 
food webs that benefit host health by promoting epithelial barrier function and immune 
tolerance.  
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Figure 10: A network depicting correlations among immune cells, 16S rRNA gene sequence 
diversity, cecal SCFA concentrations, cecal host mRNA expression, and cecal IgA 
concentrations.  The color turquoise is used for the cecal host mRNA expression and IgA 
concentrations, designated as “other” in the legend.  Only positive correlations are shown 
with a Spearman coefficient >0.6 and a p-value < 0.05. 
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Discussion 
RPS supports microbial-host interactions and enhanced SCFA production 
  We assessed the effect of dietary RPS on swine gut bacterial diversity, bacterial 
function, and host immune function.  RPS is an easily accessible metabolic input for gut 
microbes and can encourage increased production of SCFAs, particularly butyrate, which are 
known to have beneficial effects on the intestinal system.  The results showed increased 
concentrations of cecal butyrate and lactate in the RPS-fed pigs compared to the control animals.  
In the distal gut lactate is converted to butyrate (36, 39-42), and the lactate observed in the 
cecum was likely converted to butyrate during colonic passage because fecal lactate 
concentrations were very low.  Additionally, in the RPS-fed pigs we observed an enrichment of 
butyrate–producing bacteria known to consume lactate.  Butyrate is well established as a 
bacterial metabolite of central importance for intestinal homeostasis and supports many aspects 
of gut health including reducing the mucosal niche for bacterial respiration (43), increased 
barrier function (10, 44), water absorption (45), and encouraging a robust yet tolerant immune 
response to commensal microbes (46-49).  This work suggests that RPS intake supports a healthy 
mucus barrier by stimulating microbial SCFA production, particularly butyrate, which 
encourages immunological tolerance and a robust mucosal barrier. 
In addition to differences mediated by RPS on butyrate-producing microbes, other effects 
are likely a result of feedback between intestinal bacteria and host tissues. The butyrate produced 
by gut bacteria is oxidized by host tissues, thereby limiting the amount of oxygen available at the 
mucosa (43). This establishes a mucosal environment favoring microbial fermentation over 
respiration, and therefore more SCFA production, and  limits inflammation-associated 
respiratory electron acceptors (21).  Consistent with this model, our results showed RPS-
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associated microbial food webs are composed of organisms known to use fermentative 
metabolisms.  Well known fermenters such as Bifidobacteria spp. and Faecalibacterium spp. 
were enriched in the RPS pigs and are associated with intestinal health in humans (50). Several 
studies have shown increased populations of these genera in pigs fed resistant starch (7, 51).   
Other genera enriched in the RPS pigs are less well known for their health benefits.  Members of 
the genus Clostridium sensu stricto 1 are not generally associated with positive health outcomes; 
however, our data suggest that members of this genus can be important for resistant starch 
degradation and intestinal health in the swine gut ecosystem. 
The results also showed a positive impact of in-feed RPS on the mucosal barrier in the 
cecum of weaned piglets. T-cell subtypes and host response profiles associated with intestinal 
health and mucosal barrier function correlated with microbial butyrate production and anaerobic 
fermentative microbes in the ceca.  Butyrate is known to generate peripheral T-regulatory cells 
(T-regs) (19, 20, 48), and these T-regs cells were significantly enriched in the RPS group and 
have been shown to be critical for intestinal homeostasis and gut barrier function(52).  
Regulatory cells help moderate immune responses to commensal microbes, reducing intestinal 
inflammation and the mucosal availability of immune-derived electron acceptors, limiting 
microbial respiration (43, 53).  Additionally, the results showed increased concentrations of 
luminal IgA, and T-regs have been shown to promote the mucosal IgA response, helping the host 
exert control over its microbial partners (48, 54, 55). CD4-/CD8+/CD25+/FoxP3+ T-cells are 
less well studied than CD4+ T-regs, but recent work has shown they are an equally important 
regulatory cell type in humans and mice (56), and our data suggest they are important in swine as 
well.   We see evidence that these host-microbe interactions enhance the mucosal barrier by 
increasing the expression of MUC2, IL-6, DEFB1 in the cecal mucosa.  IL-6 has recently been 
114 
 
shown to be critical for maintaining the mucosal barrier (Kuhn et. al 2017, in review) and has 
also been shown to be important for strong IgA responses (57).   Our data suggest that RPS 
intake encouraged a protective mucus layer containing more barrier-enhancing molecules such as 
DEF1B and IgA as well as increased mucosal tolerance and a reduced niche for microbial 
respiration. 
Examination of the microbiota in the control group reveals enriched members that could 
be detrimental to host health.  Bacteria enriched in the control animals have been previously 
associated with microbial respiration, intestinal inflammation and dysbiosis in humans and mice 
(58). In particular, members of the genus Mucispirillum have been shown to thrive in inflamed, 
oxygenated mucosal environments.  Loy et. al. recently completed a detailed analysis of the 
genome of  Mucispirillum schaedleri and showed that this organism utilizes nitrate or free 
oxygen as terminal electron acceptors for respiration (59).  This organism is unable to utilize 
complex molecules and relies on other microbes to release simple substrates for its consumption 
(SCFAs, amino acids, monosaccharides etc.), suggesting that it is not a sole causative agent of 
intestinal dysbiosis but rather an indicator of mucosal inflammation and conditions favoring 
microbial respiration.  Our results showing direct correlations between this microbe and immune 
cells associated with tissue damage strengthen this connection.   
The host response in the control animals is also suggestive of an inflammatory state. The 
immune cell types that were expanded in the control animals contain cells responsible for 
cytotoxic activity, although we did not detect any well-known intracellular pathogens in our 16S 
rRNA gene sequence analysis of the cecal mucosa. However, we did detect consistent 
enrichment of Helicobacter in control animal tissues, and bacteria from this genus have been 
shown to be facultative intracellular pathogens (60) , with H. canadensis shown to cause diarrhea 
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in humans (61), and has been previously detected in swine (62).  Sequences detected in our pigs 
most closely match H. equorum (100% V4 identity) and H. canadensis (99.8% V4 identity).  A 
recent study suggests that non-H. pylori Helicobacter species may be a cause of irritable bowel 
disease (IBD) in humans (63).  It is likely that there is not one causative agent for the expansion 
of cytotoxic T-cell subtypes, but their presence suggests a compromised mucosal barrier and the 
invasion of the piglet mucosa by the commensal microbiota causing tissue damage and the CD8+ 
cell expansion.  
The RPS diet did not completely protect pigs from experiencing immune activation 
towards intestinal commensal bacteria.  Many nodes belonging to the immune activation 
subnetwork were equally represented in both groups.  For example, Double positive CD25+ T-
cells are prominent members of this immune activation subnetwork and were not differentially 
abundant between the two groups.  These cells have been shown to be common in swine and are 
highly activated, primed lymphocytes (64, 65). Similarly, two proteobacterial species were found 
to correlate with CD3+CD4+CD8a-CD25+FoxP3- cells, a Campylobacter OTU, and an 
unclassified Proteobacteria OTU.  This finding supports the idea that many Proteobacteria 
species exploit or thrive under conditions of inflammation in swine.  As these results are only 
correlations it is not clear if these OTUs are the cause of the inflammation or are merely thriving 
in conditions brought on by inflammation, or some combination of both.  This suggests that not 
all individuals react in the same way to dietary prebiotics such as RPS, a concept that has been 
demonstrated in humans and mice (66).  To optimize the health benefits of RPS it may be 
necessary to co-administer some of the RPS-degrading bacteria identified in this study to aid in 
the establishment of beneficial bacterial food webs and interactions with the host. 
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Weaning-associated changes in the microbiota and potential challenges 
In addition to the dietary modulation by RPS, the experimental design also yielded 
information regarding microbiota changes after weaning.  The transition from a milk-based diet 
to a solid corn-based diet induced a major shift in the swine gut microbiota, as has been reported 
in other studies (67, 68).   This shifting microbiota leaves the piglet susceptible to opportunistic 
infections. Previous work has shown that weaning is associated with transient intestinal 
inflammation (69), and health problems associated with weaning are well documented (1).  As 
the microbiota matures, the intestinal ecosystem becomes more resilient to perturbations and 
develops inherent resistance to colonization by new microbes or pathogens (70). One way to 
support the piglet’s intestinal microbiota to be resistant to perturbations and disease is to 
establish a healthy bacterial community.  The data presented in this paper show that dietary RPS 
promotes bacterial fermentation and supports the host mucosal functions, suggesting that dietary 
RPS could support gut microbiota functions associated with health as the piglet and its 
microbiota mature. 
As the bacterial populations change after weaning, so do the enzymatic capabilities of the 
fecal microbiota.   The results show that the glycan utilization of the intestinal microbiota 
changes in parallel with the change in bacterial community composition.  Rates for the 
breakdown of plant-derived sugar linkages increased through the 21 days post-weaning, whereas 
enzymatic activities to mucin-derived substrates showed the opposite trend.  High activity 
towards fucose-containing polymers, as shown in our results, is associated with bacterial growth 
on mucins (71), and the cleavage of fucose by commensal bacteria has been shown to benefit the 
growth of some pathogens (72). These data show that the enzymatic potential of the fecal 
microbiota is changing throughout the first 3 weeks post-weaning.  Furthermore, these data show 
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that early in weaning, the intestinal microbiota degrades the host mucus barrier as an energy 
source as it adjusts to the solid corn-based diet, suggesting one potential cause of common 
weaning-associated intestinal distress in piglets.  
Conclusions 
Our study reveals the specific microbial interactions involved in the microbial breakdown 
of resistant starch and identifies specific bacterial groups which could be co-administered with 
RPS to enhance its effects.  Additionally, this work reveals both beneficial and potentially 
negative interactions between the commensal microbiota and mucosal immune system that can 
inform future strategies to mitigate weaning-associated complications.  Together, these data 
provide valuable insights into the host-microbe interactions in the intestinal mucosa of swine and 
will help inform management practices with the potential to benefit both animal health and food 
safety.   
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Supplemental Material 
Table S1: Composition of diets. All diets were formulated at Iowa State University. 
  
Non-
Amended 
Phase I Diet 
Amended           
Phase 1 Diet 
Non-
Amended 
Phase 2 Diet 
Amended  
Phase 2 Diet 
Corn, yellow dent 49.00% 44.00% 61.06% 56.06% 
Soybean meal (46.5% CP*) 28.20% 28.20% 27.00% 27.00% 
Casein 2.70% 2.70%  - 
Lactose 10.00% 10.00% 2.50% 2.50% 
Fish meal (menhaden) 4.50% 4.50% 4.66% 4.66% 
Soybean oil 2.00% 2.00% 1.65% 1.65% 
L-lysine HCl 0.35% 0.35% 0.38% 0.38% 
DL-methionine 0.15% 0.15% 0.12% 0.12% 
L-threonine 0.13% 0.13% 0.12% 0.12% 
L-tryptophan 0.02% 0.02% 0.01% 0.01% 
L-valine 0.11% 0.11% - - 
Monocalcium phosphate 
(21%) 
1.15% 1.15% 0.96% 0.96% 
Limestone 0.80% 0.80% 0.74% 0.74% 
Salt 0.50% 0.50% 0.40% 0.40% 
NSNG Nursery Vitamin 
Premix 
0.25% 0.25% 0.25% 0.25% 
NSNG Trace Mineral Mixa 0.15% 0.15% 0.15% 0.15% 
MSP[RS]b Raw Potato Starch - 5.00% - 5.00% 
a: National Swine Nutrition Guide 
b: Manitoba Starch Products Resistant Starch 
*: Crude Protein 
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Table S2: TaqMan® Gene Expression Targets for qRT-PCR.  
Symbol Gene Name Accession Assay ID Function 
DEFB1 defensin β1 NM_213838 Ss03381769_u1 antimicrobial peptide 
FFAR2 free fatty acid 
receptor 2 
NM_001278758 Ss03374174_s1 SCFA receptor 
IL-10 interleukin-10 NM_214041 Ss03382372_u1 cytokine signaling 
IL-17 interleukin-17A NM_001005729 Ss03391803_m1 cytokine signaling 
IL-22 interleukin-22 AY937228 Ss03373919_m1 cytokine signaling 
IL-1β interleukin-1β NM_214055 Ss03393804_m1 cytokine signaling 
IL-6 interleukin-6 NM_214399 Ss03384604_u1 cytokine signaling 
MUC2 small intestinal 
mucin 
EU143549 Ss03377386_u1 mucus layer defense 
PR39 PR-39 NM_214450 Ss03385004_u1 antimicrobial peptide 
TGFβ transforming 
growth factor β 
NM_214015 Ss03382325_u1 cytokine signaling 
ACTβ β -actin AK237086 Ss03376081_u1 reference gene 
All primers were labeled with FAM dye and specific for sus scrofa (Thermo Fisher Scientific). 
 
Figure S1: Representative flow plot used for determining frequency of T cell populations in the 
cecum. 1A) Live cells gating (negative for stain), 1B) CD3+ gating 1C) CD4 and Cd8α gating of 
live CD3+ cells and 1D) representative gating for CD25 and FoxP3 staining of indicated T cell 
populations - the blue dots are representative of CD4+/ CD8α - population and the red dots are 
representative of CD4+/ CD8α+ population. 
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Table S3: PERMANOVA results showing treatment group differences in community structure across 
time and tissues.  Both 16S and but based communities. Calculated with vegan’s Adonis function. 
 
Comparison F.Model R2 p.value gene day tissue 
feces_0_control vs feces_0_RPS 0.597851 0.022477 0.9073 16S 0 feces 
feces_12_control vs feces_12_RPS 0.974797 0.037529 0.4307 16S 12 feces 
feces_15_control vs feces_15_RPS 1.94773 0.072278 0.0159 16S 15 feces 
feces_19_control vs feces_19_RPS 2.607228 0.105954 0.0017 16S 19 feces 
feces_21_control vs feces_21_RPS 5.257901 0.179709 1.00E-04 16S 21 feces 
cec_cont_RNA_21_control vs cec_cont_RNA_21_RPS 1.860549 0.134233 0.0566 16S 21 cec_cont_RNA 
cecum_21_control vs cecum_21_RPS 2.64312 0.180503 0.0085 16S 21 cecum 
colon_21_control vs colon_21_RPS 1.441706 0.107256 0.1439 16S 21 colon 
ileum_21_control vs ileum_21_RPS 2.67778 0.308579 0.0367 16S 21 ileum 
feces_0_control vs feces_0_RPS 0.794 0.029633 0.5793 but 0 feces 
feces_12_control vs feces_12_RPS 0.746653 0.027916 0.7542 but 12 feces 
feces_15_control vs feces_15_RPS 1.522014 0.057387 0.0925 but 15 feces 
feces_19_control vs feces_19_RPS 3.582779 0.151924 1.00E-04 but 19 feces 
feces_21_control vs feces_21_RPS 3.880003 0.129853 3.00E-04 but 21 feces 
cec_cont_RNA_21_control vs cec_cont_RNA_21_RPS 1.694801 0.133504 0.054 but 21 cec_cont_RNA 
cecum_21_control vs cecum_21_RPS 1.859664 0.134178 0.0483 but 21 cecum 
colon_21_control vs colon_21_RPS 1.36554 0.102169 0.2063 but 21 colon 
ileum_21_control vs ileum_21_RPS 2.333303 0.162789 0.0112 but 21 ileum 
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Table S4: Community dispersions across time and tissues within and between groups for both 16S and 
but communities.  Calculated with a permutation test of vegan’s betadisper function. 
Comparison 16S p value but p value 
cec_cont_RNA_21_control vs cec_cont_RNA_21_RPS 0.886 0.028 
cecum_21_control vs cecum_21_RPS 0.007 0.012 
colon_21_control vs colon_21_RPS 0.129 0.078 
feces_0_control vs feces_0_RPS 0.942 0.714 
feces_0_control vs feces_12_control 0.299 0.758 
feces_0_control vs feces_15_control 0.001 0.744 
feces_0_control vs feces_19_control 0.003 0.064 
feces_0_control vs feces_21_control 0.001 0.223 
feces_0_RPS vs feces_12_RPS 0.042 0.962 
feces_0_RPS vs feces_15_RPS 0.001 0.25 
feces_0_RPS vs feces_19_RPS 0.009 0.353 
feces_0_RPS vs feces_21_RPS 0.001 0.013 
feces_12_control vs feces_12_RPS 0.351 0.873 
feces_12_control vs feces_15_control 0.015 0.464 
feces_12_control vs feces_19_control 0.081 0.02 
feces_12_control vs feces_21_control 0.183 0.065 
feces_12_RPS vs feces_15_RPS 0.189 0.139 
feces_12_RPS vs feces_19_RPS 0.429 0.181 
feces_12_RPS vs feces_21_RPS 0.001 0.004 
feces_15_control vs feces_15_RPS 0.272 0.686 
feces_15_control vs feces_19_control 0.341 0.108 
feces_15_control vs feces_21_control 0.175 0.363 
feces_15_RPS vs feces_19_RPS 0.748 0.775 
feces_15_RPS vs feces_21_RPS 0.001 0.075 
feces_19_control vs feces_19_RPS 0.839 0.055 
feces_19_control vs feces_21_control 0.645 0.283 
feces_19_RPS vs feces_21_RPS 0.001 0.041 
feces_21_control vs feces_21_RPS 0.003 0.175 
ileum_21_control vs ileum_21_RPS 0.799 0.569 
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CHAPTER 5: PROGRESS TOWARDS RESEARCH GOALS AND DIRECTIONS FOR 
FUTURE WORK 
 
Summary 
 Development of non-antibiotic-based approaches and strategies to support the health of 
commercially-important livestock species is essential.  Increasingly, the spread of antimicrobial 
resistance genes is becoming both a food safety and animal health concern, and efforts to 
mitigate this risk are important.  Consequently, investigating ways to improve swine health 
without the use of antibiotics is a central research topic.  Gut health is critical to the overall 
wellbeing of an animal, so the intestinal microbiome is a potential intervention point for 
modulating health.  However, mechanistic knowledge of the complexities of the host-microbial 
ecosystem is lacking, and this impedes the rational design of strategies to modulate the 
microbiota.  In this final chapter, specific advancements contributed by this thesis towards the 
overall research goals are outlined, and the future work that is enabled and called for by these 
efforts is discussed. 
Chapter 1: 
This chapter contributes significantly to the broader scientific knowledge of 
understanding butyrate production in the gut by more accurately defining but genes and 
differentiating them from their paralogues.  The but gene is similar to many other CoA 
transferases and as such is easily misannotated.  This work provides a way to differentiate 
between but genes  and non-but genes by identifying amino acid sequence motifs associated with 
But activity.  This will facilitate accurate annotations of genomes, metagenomes, and 
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metatranscriptomes, and will clarify whether an organism harboring homologues of this gene is 
likely a butyrate-producer or not. 
 Additionally, the degenerate primer set that is described is a useful tool for surveying one 
population within the butyrate-producing community:  bacteria harboring a butyrate transferase.  
This primer set targets regions of the but gene associated with activity, and so it is suitable for 
but gene-targeted investigations in many microbial ecosystems in addition to swine.  This primer 
set allows us to amplify and sequence a fragment of the but gene from a phylogenetically diverse 
selection of butyrate producers.   By combining this with high-throughput sequencing platforms, 
such as Illumina’s MiSeq instrument, it is now possible to easily and rapidly survey the butyrate-
producing community of hundreds of samples simultaneously.  This ability to quickly survey a 
high number of samples for an important microbial function greatly increases the capacity to 
evaluate the effects of dietary changes or disease states on this community and important gut 
function.   
 The initial investigations into the but gene-based community in swine revealed several 
important findings.  Diverse but genes in the proximal colon of swine from both DNA and RNA-
based libraries were detected.  Interestingly, the RNA-based communities were more even and 
diverse than the DNA-based communities.  This is an important finding, suggesting that the most 
numerically abundant butyrate producers are not necessarily the most transcriptionally active.  
Without amplifying but gene-fragments from RNA it would be easy to assume that the most 
abundant butyrate-producers are the most important ones and overlook a potentially critical part 
of this community.   This finding stresses the need to learn which organisms express their but 
genes under various conditions, gut segments, or in association with other microbes.  With this 
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information, it is now possible to investigate the precise conditions in which various butyrate-
producing bacteria express their but genes, and by proxy, produce butyrate.   
 This investigation also revealed the limitations of current knowledge of the swine-
associated butyrate-producing community.  Although many sequences were detected that were 
identical or very similar to organisms that have been cultured and characterized, the vast 
majority of the sequences detected did not closely match known but genes. Many more only 
matched organisms that have only been detected in metagenomes.  This feature of data generated 
from these primers makes it difficult to draw conclusions about organisms that do not closely 
match entries in the databases.   
Although the limited knowledge of this community is somewhat disappointing, this 
finding is important as it can inform future targeted culturing efforts.  By identifying gaps in the 
knowledge of butyrate-producing bacteria, rational culturing experiments can be designed to fill 
these gaps.  The but amplicon data can be combined with knowledge of the gut segment or 
environment from which it originated to help select culture conditions.  Additionally, if other 
molecular surveys are available, such as 16S rRNA gene sequence data, these data can be used to 
look for correlations with other bacterial taxa.  Once putative co-occurring taxa have been 
identified, knowledge of their metabolisms and ecological niches can further refine the culture 
conditions used to isolate these novel butyrate producers.  After potential isolates have been 
obtained, the funbuts primers can be used to screen them for the but gene.  In theory, hundreds of 
isolates can be screened for the presence of the but gene simultaneously using only basic 
molecular laboratory equipment. 
However, the work in this chapter can also be improved upon. Specifically, there is a 
need to address the significant amplification bias observed with the funbuts primers.  These 
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primers have an amplification bias for certain sequences and against others, leading to a distorted 
view of the butyrate-producing community when used in sequence-based surveys.  Additionally, 
in the case of low sequencing depth it is possible that low-abundance sequences that these 
primers are biased against would be missed completely.  These primer biases likely derive from 
the inosine bases present in the primers.  Although inosine is considered to be a ‘universal’ base, 
it is known that it does have some base-pairing biases (1).   The replacement of synthetic non-
naturally occurring nucleotides could help mitigate these biases (2).  
 Additionally, the degeneracy of these primers could also contribute to bias.  Synthetic 
degenerate pyrimidine and purine analogs have been developed that could help reduce 
degeneracy in these primers without sacrificing their ability to target a broad range of sequences.  
The synthetic bases P and K have been shown to pair with any pyrimidine or purine respectively 
with little to no bias (3).  These bases could be incorporated into the funbuts primers and 
significantly reduce the degeneracy-associated issues.  However, these synthetic nucleotides can 
be prohibitively expensive for certain applications.  As their use increases, the price of primers 
manufactured using these bases will likely fall, and using these modifications may become more 
accessible in the near future. 
The work outlined in chapter 1 contributes significantly to the understanding of the 
butyrate-producing community in swine and provides valuable tools to make future studies of 
this community easier.  The butyrate-producing community is central to host health and 
resistance to disease, and this work contributes to the broader research goals by enabling us to 
more directly observe this community.   
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Chapter 2 
 The work outlined in this chapter greatly increases the available knowledge of one 
common butyrate-producing bacterium, Butyricicoccus porcorum strain BB10, from the swine 
intestinal microbiota.  Detailed biochemical and genomic investigation of this bacterium, and 
comparison with other members of this genus, yields a greater understanding of the types of 
niches filled by members of this genus. Additionally, the description of this new species and 
publication of its genome will aid other researchers when they encounter this or similar bacteria 
in their own studies. 
 Strain BB10 has many qualities that make it an attractive species to use as a health-
promoting probiotic organism.  This strain was isolated from the mucosa of a healthy pig; 
together with biochemical, genomic, and phylogenetic data, this suggests that strain BB10 is able 
to effectively colonize the mucosa of swine.  Furthermore, it is able to produce large quantities of 
butyrate from plant as well as host-derived sugars.  Together these data suggest that BB10’s 
niche in the swine intestinal ecosystem is that of a mucosal scavenger, which is an organism that 
colonizes the mucosa and consumes mono- or oligosaccharides that have been released by the 
enzymatic processes of other organisms.  These traits can potentially benefit the host by limiting 
the simple sugars available for potential mucosal pathogens while simultaneously providing 
butyrate to host tissues. 
 Despite these promising characteristics, significant obstacles exist to using strain BB10 as 
a probiotic.  Culture techniques used in this investigation have revealed strain BB10 to be a strict 
anaerobe with little to no tolerance for oxygen exposure.  This presents a challenge as 
maintaining it under anaerobic conditions during administration to animals is difficult.  
Additionally, a rapid loss of viability was observed when culturing strain BB10.  Cultures of 
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strain BB10 needed to be reinoculated into fresh media every 5 days for continued viability, 
suggesting a limited storage potential for this strain.  Future studies into altering culture 
conditions for improved long-term viability are required if this organism is to be used as a 
probiotic. 
This investigation provided some potential solutions for the aforementioned problems.  
Many gut-associated anaerobes utilize sporulation to circumvent these transmission and 
dispersion difficulties (4), and many genes for sporulation were detected in strain BB10’s 
genome.  Unfortunately, sporulation was unable to be induced in culture, although this negative 
result does not mean it is incapable of producing spores.  Future culturing studies that attempt to 
more closely mimic strain BB10’s preferred intestinal habitat, including co-culturing techniques 
with potential bacterial partners, may reveal the conditions necessary for sporulation or 
otherwise enhance its survivability. 
Data from this chapter indirectly suggests ways of enhancing butyrate production without 
directly administering live organisms.  Strain BB10 is dependent on the activities of other 
microbes to break down dietary fibers into smaller subunits that it can metabolize.  This 
information can be used to identify other microbes that digest dietary fiber and release substrates 
that can support species like strain BB10 via cross-feeding interactions.  Administering both 
dietary fiber and the primary degraders of this fiber will likely benefit secondary degraders or 
scavengers, such as BB10, and support butyrate production in the hindgut. 
The work in chapter 2 advances the broader research goals by providing detailed 
information for one common butyrate-producing bacterium.  The knowledge of strain BB10 can 
be extrapolated to other organisms that occupy similar niches.  This work also improves 
reference databases through the publication of the draft genome containing a biochemically 
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validated annotation of the butyrate transferase gene, and enables other researchers to study this 
microbe through the publication of a formal species description and the sharing of this strain in 
public culture collections.  Future work may enable us to administer strain BB10 as a probiotic 
organism to help support butyrate production in swine. 
Chapter 3: 
 The work outlined in chapter 3 is a description of the successful modulation of the swine 
intestinal microbiota during weaning, which is a time of significant stress.  The maturation of the 
microbiota after weaning was investigated and some key enzymatic functions were examined.  
These data suggest that raw potato starch (RPS) administration provided potential benefits for 
hindgut health at the end of the first 3 weeks after weaning by supporting beneficial bacterial 
populations, bacterial food webs, and their interactions with the host. 
This work demonstrates that the enzymatic capabilities of the piglet’s intestinal 
microbiota are changing in the weeks after weaning.  Curent understanding of how the 
maturation of these activities contributes to susceptibility to disease is still limited, but 
preliminary data suggests that commensal degradation of the mucus barrier may play a role in 
common weaning-associated disorders.  Future work is needed to more accurately investigate a 
broad selection of enzymatic activities throughout the post-weaning period, and how changes in 
these activities contribute to disease resistance and health in the host. 
The results also showed that administration of dietary RPS during the post-weaning 
period modifies the intestinal microbiota in several gut environments (i.e., small intestine, large 
intestine).  Additionally, the inclusion of RPS significantly altered the microbial production of 
SCFAs, and some of the microbial food webs and interactions responsible for the altered SCFA 
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production profiles were revealed.  The host responses in the cecal mucosa were significantly 
changed in the RPS-fed group and these changes are associated with immune tolerance and 
mucosal barrier function.  Conversely, the control animals had an enrichment of immune cells 
and bacterial species associated with tissue inflammation and microbial respiration.  Reduced 
gene expression for important mucosal barrier functions in the control animals relative to the 
RPS-fed animals was observed.  These data suggest that the control animals may have had 
reduced colonization resistance to opportunistic pathogens compared with the RPS-fed animals.    
Additionally, more research is required to determine if the changes between the treatment 
groups are protective against common weaning-associated pathologies.  No overt health 
differences were detected between the two groups, but no pathogen challenge was included in 
this trial.  The group differences that were detected are promising and align with models of 
increased colonization resistance; however, concomitant infection and RPS administration trials 
are needed to confirm any potential protective benefits.   
Conclusions 
This work represents significant progress towards the broader research goals through 
advancing understanding of butyrate production in hind-gut ecosystems.  New tools to more 
accurately survey one part of this community are outlined,a detailed description of a common 
swine-associated butyrate-producing bacterium is given, and a prebiotic treatment is described 
that can enhance butyrate production and encourage healthy host-microbe partnerships.  With 
this knowledge in hand it will be easier to design effective alternative treatments to manipulate 
intestinal communities for the improvement of animal health and resistance to disease.   
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